Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,48786,-0.0240962291997397,0.018100808844175,-0.0595738145343228,0.0113813561348433,0.183127527747098
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,45062,-0.00615431506551525,0.020642586477391,-0.0466137845612015,0.034305154430171,0.765601662807827
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1070.Time spent watching television (TV),49950,-0.055339029681224,0.0178178186645763,-0.0902619542637936,-0.0204161050986545,0.00189952236826415
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1080.Time spent using computer,45001,-0.0294961988663229,0.0192761007432967,-0.0672773563231845,0.00828495859053861,0.12598335572402
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1090.Time spent driving,43869,-0.0551554132698399,0.0201882949248718,-0.0947244713225887,-0.0155863552170911,0.00629969683443158
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1160.Sleep duration,51753,0.017224658964964,0.0168331193410814,-0.0157682549435556,0.0502175728734836,0.306193769803727
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34444,-0.0257477890265492,0.0206301606832977,-0.0661829039658127,0.0146873259127144,0.212034730108108
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34444,0.0478478932749693,0.0203843190183362,0.00789462799903033,0.0878011585509083,0.0189288900717872
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34444,0.0461330654441786,0.0238675600712114,-0.000647352295395837,0.092913483183753,0.0532779567058785
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34444,0.0516723116288029,0.0249693686511706,0.00273234907250852,0.100612274185097,0.0385301483338752
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34444,0.0727845169348526,0.0256096353351863,0.0225896316778874,0.122979402191818,0.00449065900682789
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34444,0.0265738779253095,0.0494033467429991,-0.0702566816909688,0.123404437541588,0.590659945841586
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34444,0.0173152749382242,0.0507556746955938,-0.0821658474651395,0.116796397341588,0.732997782135887
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34444,0.00919298743871971,0.0358124720237041,-0.0609994577277403,0.0793854326051797,0.797416959041581
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34444,0.0641008941257044,0.0264199379860071,0.0123178156731304,0.115883972578278,0.0152731171340135
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34444,0.0458275449405194,0.0184940790160597,0.00957915006904239,0.0820759398119963,0.0132291627855404
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34444,0.0318741520407974,0.026276334501058,-0.0196274635812764,0.0833757676628711,0.225142949594635
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34444,0.0191118764799657,0.0150655656722697,-0.0104166322376829,0.0486403851976144,0.204618773453953
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34444,0.0543797515087554,0.0193087214277043,0.016534657510455,0.0922248455070557,0.00486654717090663
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34444,0.0683106589795301,0.0293136434647089,0.0108559177887005,0.12576540017036,0.0198070586975648
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34444,0.00947564253736888,0.0276924622233907,-0.0448015834204768,0.0637528684952146,0.732226691180572
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34444,0.0431636045362952,0.0342022128607893,-0.0238727326708518,0.110199941743442,0.206972261876425
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34444,0.00231189083222329,0.0322921013012569,-0.0609806277182403,0.0656044093826868,0.942927103944387
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34444,0.0457159382710531,0.0215934721952002,0.00339273276846073,0.0880391437736454,0.0342730597095233
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34444,0.0488633642611733,0.0204151101527435,0.00884974836179613,0.0888769801605505,0.0167062406976609
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34444,0.0290701725915152,0.0251929905013143,-0.0203080887910608,0.0784484339740911,0.248567535858911
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,34452,0.0570168816112922,0.0285780074782815,0.00100398695386056,0.113029776268724,0.0460541237879854
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34454,0.0351062524279738,0.0282016362631555,-0.020168954647811,0.0903814595037586,0.21322166262329
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34452,0.0717058994403793,0.0310218205994162,0.0109031310655235,0.132508667815235,0.0208262006281096
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120098.Mobility problems today,34457,0.0780952800037849,0.0349098997288364,0.00967187653526558,0.146518683472304,0.025303622867488
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120099.Self-care problems today,34457,0.0431692039605185,0.0543866786924306,-0.0634286862766455,0.149767094197683,0.427361143219703
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120100.Problems doing usual activities,34457,0.0539426172068952,0.0328518797823234,-0.0104470671664586,0.118332301580249,0.100620753539682
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120101.Pain or discomfort today,34457,0.0369840428425552,0.0285686138740541,-0.0190104403505907,0.0929785260357012,0.195497156136421
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120102.Anxiety or depression today,34457,0.00607036624956877,0.0339199285894278,-0.0604126937857096,0.0725534262848472,0.85797123982364
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,34422,-0.0174353548942814,0.00650523099208062,-0.0301856076387594,-0.00468510214980337,0.00736911683321638
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34441,-0.00569110901990471,0.0338951168942405,-0.0721255381326161,0.0607433200928067,0.866662400110736
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34425,-0.000599969317457979,0.0346902928765952,-0.0685929433555847,0.0673930047206687,0.986201584925834
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34446,-0.00168031066241725,0.0281834407978901,-0.0569198546262819,0.0535592333014474,0.952459021181632
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34446,0.0359110504028952,0.0289341338424995,-0.0207998519284038,0.0926219527341942,0.214584867285955
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34443,-0.00353499745489995,0.0352271140942792,-0.0725801410796871,0.0655101461698872,0.920069343781939
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34417,-0.0161305575805847,0.0361858840836522,-0.087054890384543,0.0547937752233736,0.65577301583793
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34448,-0.0023390328290898,0.0362798511719709,-0.0734475411261528,0.0687694754679732,0.948595656912558
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34432,0.0776564688862982,0.0544164571039832,-0.0289997870375089,0.184312724810105,0.153587268958994
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34381,-0.0349640355524878,0.0708473717285692,-0.173824884140483,0.103896813035508,0.621661092084872
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31431,0.030253509634926,0.0379878857468549,-0.0442027464289096,0.104709765698761,0.425825207172593
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48728,-0.000940085372340378,0.0400652480538398,-0.0794679715578664,0.0775878008131857,0.981280454328984
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47448,-0.00715191895128863,0.0242385399124982,-0.0546594571797852,0.0403556192772079,0.767947636940395
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,50729,-0.00595974836779118,0.0172276865155146,-0.0397260139381998,0.0278065172026174,0.729390406567022
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50191,-0.0139302486515006,0.0185258245463407,-0.0502408647623284,0.0223803674593272,0.452095806381234
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,50710,0.0857907421026601,0.0183991273173125,0.0497284525607277,0.121853031644593,3.13494494620185e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49173,0.0596001364837777,0.0193651197489029,0.021644501775928,0.0975557711916274,0.00208823801712642
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X134.Number of self-reported cancers,51981,0.108561411146951,0.0386745747248854,0.0327592446861756,0.184363577607726,0.00500320992064204
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51981,0.0317755637773048,0.0168444104637819,-0.00123948073170784,0.0647906082863174,0.0592492255948772
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",51981,-8.09986727326466e-05,0.0168352123323213,-0.0330780148440825,0.0329160174986172,0.996161214647362
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,51981,0.092633804701935,0.0167440721391513,0.0598154233091984,0.125452186094672,3.18808815499509e-08
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1438.Bread intake,51108,0.0223171012921217,0.00418265540279967,0.0141190967026344,0.0305151058816091,9.59730034269595e-08
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1458.Cereal intake,50348,0.1318336661071,0.017350658022972,0.0978263763820752,0.165840955832126,3.10209823545429e-14
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1488.Tea intake,50891,0.0145126120501806,0.00396364119187803,0.00674387531409967,0.0222813487862616,0.000251285084313496
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1498.Coffee intake,49658,0.0475636881233213,0.0175658699126345,0.0131345830945576,0.081992793152085,0.00677891011694141
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1528.Water intake,49972,0.00938801817187176,0.0179836776927602,-0.0258599901059383,0.0446360264496818,0.601653913625456
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,42954,-0.119481860856419,0.0205444505679666,-0.159748983969634,-0.0792147377432049,6.1317714520865e-09
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42948,-0.0965123741179442,0.0210432615072377,-0.13775716667213,-0.0552675815637583,4.53864414381577e-06
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42996,-0.117564822810567,0.0230820168596913,-0.162805575855562,-0.0723240697655717,3.55129784090502e-07
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,42920,-0.0748475959956102,0.0230998636015126,-0.120123328654575,-0.0295718633366456,0.0011966129858123
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,42986,0.0619098030599421,0.0418670843555821,-0.0201496822769989,0.143969288396883,0.139230943664296
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45484,0.00536966322131613,0.0201419782186924,-0.034108614087321,0.0448479405299533,0.789786891541609
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1807.Father's age at death,40627,0.00567602510139342,0.00559395994153989,-0.00528813638402475,0.0166401865868116,0.310277649805526
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1845.Mother's age,39893,0.00482527048421349,0.00853249244854292,-0.0118984147149306,0.0215489556833576,0.571730002295655
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1873.Number of full brothers,51476,0.00749179708425451,0.0168411742121923,-0.0255169043716424,0.0405004985401514,0.656431613043933
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1883.Number of full sisters,51478,0.0283777610114323,0.0168971281268407,-0.00474061011717546,0.0614961321400401,0.0930770797103104
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20015.Sitting height,51748,-0.014716673939097,0.00531126834451102,-0.0251267598943386,-0.00430658798385535,0.00559489356798659
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20016.Fluid intelligence score,32722,-0.0185168951255639,0.0278288844008397,-0.0730615085512097,0.0360277183000819,0.505822239672098
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20018.Prospective memory result,33045,0.118898941773499,0.040148811611692,0.0402072710145828,0.197590612532415,0.0030697181469577
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32635,0.00277379607774036,0.00751041627962615,-0.0119466198303269,0.0174942119858076,0.711893255226889
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32627,0.0169938606679387,0.00747316455197648,0.0023464581460648,0.0316412631898126,0.0229909800627256
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51667,0.0123880488777633,0.00421934874229929,0.00411812534285668,0.0206579724126699,0.00332736132025564
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48739,-0.0106529908435375,0.00913698410123089,-0.02856147968195,0.00725549799487507,0.243658042329319
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48310,-0.0406880495214802,0.0207914772319429,-0.0814393448960882,6.3245853127801e-05,0.0503637594839762
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48277,0.00487011492978632,0.0278839092328485,-0.0497823471665968,0.0595225770261694,0.861350746500425
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48307,0.00641125849501215,0.0213681116843355,-0.0354702404062855,0.0482927573963098,0.764150257243117
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48310,-0.00300384601243587,0.0155906849230302,-0.0335615884615751,0.0275538964367034,0.847219585197287
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48474,0.00524817763471975,0.0120291301608826,-0.0183289174806101,0.0288252727500496,0.662630860254057
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48414,-0.0235111251211827,0.0156289121811076,-0.0541437929961536,0.00712154275378825,0.132507902689835
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48314,0.001542691210187,0.0187948870085683,-0.0352952873266068,0.0383806697469808,0.934583477628952
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48433,0.0115283479619532,0.0149438280384603,-0.017761554993429,0.0408182509173354,0.440450369507864
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48590,-0.00327997201387621,0.00944849859504448,-0.0217990292601634,0.015239085232411,0.728487491127226
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48438,-0.0180698609815591,0.0129668566346326,-0.0434848999854389,0.00734517802232076,0.163468515764959
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49784,0.029109214796644,0.0109862251978014,0.00757621340895327,0.0506422161843347,0.00806335586254938
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49653,-0.0266089373468483,0.0177131196657237,-0.0613266518916667,0.00810877719797014,0.133053494743872
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49596,0.0293703248658291,0.0372206039008326,-0.0435820587798029,0.102322708511461,0.430067954448479
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49643,-0.00228748273313253,0.0159840878667157,-0.0336162949518953,0.0290413294856302,0.886204429739923
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49730,0.00378354658785631,0.0129985336515682,-0.0216935793692173,0.0292606725449299,0.770996386944614
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49648,-0.0215333432426287,0.0212425198274395,-0.06316868210441,0.0201019956191527,0.31073990849816
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49626,-0.0141829637431914,0.0201142925944662,-0.0536069772283451,0.0252410497419624,0.480742747168227
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49663,0.0153399226609723,0.0152569877115823,-0.014563773253729,0.0452436185756736,0.314696444956514
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49666,-0.0120694020602704,0.0179227572337061,-0.0471980062383345,0.0230592021177936,0.500691166800684
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49879,0.000616456021302845,0.00862249596459253,-0.0162836360692985,0.0175165481119042,0.943005214226197
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49715,0.00516985941538584,0.0133935383459769,-0.0210814757427288,0.0314211945735005,0.699502409758615
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46948,0.0175056343928626,0.0175769108954796,-0.0169451109622775,0.0519563797480027,0.319287365681672
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46836,0.0547217612467628,0.0980937132251709,-0.137541916674572,0.246985439168098,0.576950975554492
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46834,-0.0784021157923047,0.0859569183333094,-0.246877675725591,0.0900734441409817,0.361720685383994
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46921,-0.00219173441383158,0.0160932592999998,-0.0337345226418312,0.0293510538141681,0.891672591861585
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46841,-0.0597162229918475,0.0539812443229082,-0.165519461864748,0.0460870158810526,0.268634143476553
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46856,0.0815783443860968,0.0304068197364394,0.0219809777026756,0.141175711069518,0.00730398075683923
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46843,-0.0255392533850438,0.0409065429593241,-0.105716077585319,0.0546375708152314,0.532415936646898
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46850,0.0217295240284291,0.0364962278040108,-0.0498030824674322,0.0932621305242903,0.551588028864129
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46856,-0.0208108321392097,0.0244603574195578,-0.068753132681543,0.0271314684031236,0.394890227822509
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46860,0.0857990159339649,0.0320347273594913,0.0230109503093619,0.148587081558568,0.0074046689565528
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47042,-0.00984727073128584,0.0113178461920153,-0.0320302492676359,0.0123357078050642,0.384273463317855
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46932,0.0372760056129817,0.0166058021645787,0.00472863337040747,0.069823377855556,0.0247931140506253
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20127.Neuroticism score,46446,0.0490493169074254,0.0175519740847884,0.0146474477012401,0.0834511861136107,0.00520208954227943
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32722,0.0320935230232143,0.0281236308249643,-0.0230287933937158,0.0872158394401444,0.2538348053885
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,31591,0.00849452533231121,0.00857480838325695,-0.00831209909887242,0.0253011497634948,0.321893703201073
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31591,0.00729632040491661,0.00801698039902339,-0.00841696117716923,0.0230096019870025,0.362793770807199
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20191.Fluid intelligence score,31365,-0.00856184249166948,0.0311908548673956,-0.0696959180317649,0.052572233048426,0.783709132989903
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31365,-0.0231085273061744,0.0318573986932503,-0.0855490287449451,0.0393319741325962,0.46824529913814
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,30728,-0.0136077279953253,0.0329564037166427,-0.0782022792799451,0.0509868232892944,0.67969214297794
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20255.Spirometry QC measure,44902,0.0247150090435809,0.0225532164217274,-0.0194892951430049,0.0689193132301666,0.273155667108637
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20261.avMSE,29907,-0.00310614378340064,0.00953032182465341,-0.0217855745597213,0.0155732869929201,0.744494470551855
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20262.Myopia diagnosis,29907,0.0395650736369677,0.0404693708813448,-0.0397548932904681,0.118885040564403,0.328284213120946
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,39711,-0.0195030225196179,0.0054345693153829,-0.0301547783777684,-0.00885126666146741,0.000333337032399293
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39746,0.0305009426478212,0.00536573899634619,0.0199840942149827,0.0410177910806597,1.33587779033301e-08
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32609,0.0338931442553389,0.02605411768685,-0.017172926410887,0.0849592149215649,0.193335584964035
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32606,-0.0225099323798789,0.0522760074190583,-0.124970906921233,0.0799510421614752,0.666771471380852
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32603,0.0303993466524374,0.0582946115478048,-0.08385809198126,0.144656785286135,0.602047165043074
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32603,0.0394481608142584,0.0251693251104017,-0.00988371640212898,0.0887800380306458,0.117078198572652
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32603,-0.067665946199005,0.0405026198682262,-0.147051081140728,0.0117191887427184,0.0948254304240567
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32610,0.0820455486169561,0.0526337165492601,-0.0211165358195938,0.185207633053506,0.119079389176132
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32610,0.00840503860445198,0.0344074959345966,-0.0590336534273574,0.0758437306362614,0.807020251046376
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32610,0.022002649473822,0.0377144484396582,-0.0519176694679081,0.0959229684155521,0.559638375877605
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32610,0.0540839101743626,0.058684857787839,-0.0609384110898017,0.169106231438527,0.356763154419245
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32610,0.087082410296948,0.0686184896692712,-0.0474098294548235,0.221574650048719,0.204445990370177
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32610,-0.00247830933059004,0.0388329466249139,-0.0785908847154213,0.0736342660542412,0.949115202003262
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32610,0.00544494837714952,0.0660000007262017,-0.123915053046206,0.134804949800505,0.934251628064987
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32610,0.0162528681278172,0.0507255232600686,-0.0831691574619173,0.115674893717552,0.748666643046096
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32613,0.024309345767765,0.0682392353427872,-0.109439555504098,0.158058247039628,0.721671612941298
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32613,0.0547886866238788,0.0333289382475679,-0.0105360323413542,0.120113405589112,0.10023745363938
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32613,-0.0432537024704149,0.0463838249875598,-0.134165999446032,0.0476585945052024,0.351095157931663
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32613,-0.0179995349076943,0.0760880073621319,-0.167132029337473,0.131132959522084,0.8130021007575
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,35334,-0.0115981231050492,0.0252854284392021,-0.0611575628458852,0.0379613166357869,0.646466913010203
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,35334,-0.00646010160928239,0.0249944106667946,-0.0554491465161999,0.0425289432976351,0.796055128052169
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,35334,0.00242470469199743,0.0252050356804931,-0.0469771652417691,0.051826574625764,0.92336403420301
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20603.Liking for apples,35334,-0.00425828677557238,0.0255161572367435,-0.0542699549595896,0.0457533814084449,0.867462773575545
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,35334,-0.041095336666708,0.0254734179453363,-0.0910232358395672,0.00883256250615113,0.106714783539371
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,35334,0.00094534129491084,0.025184958597444,-0.0484171775560794,0.0503078601459011,0.970058331530272
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20606.Liking for avocados,35334,-0.0723284633493133,0.0253750030102083,-0.122063469249322,-0.0225934574493051,0.00437445924690858
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20607.Liking for bacon,35334,-0.0429009642178624,0.0253696364741302,-0.0926254517071575,0.00682352327143278,0.090857139788935
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,35334,0.00112008166377374,0.025414380214841,-0.0486921035573145,0.050932266884862,0.96484718034931
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20609.Liking for bananas,35334,0.068021769025966,0.0259324990123104,0.0171940709618377,0.118849467090094,0.00872664715396627
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35334,-0.054123587778484,0.0253886117998077,-0.103885266906107,-0.00436190865086104,0.0330440201598911
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,35334,-0.0533852570996006,0.0252225929388923,-0.102821539259829,-0.00394897493937168,0.0343182699908783
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,35334,-0.0355907826793137,0.0255366381338403,-0.0856425934216407,0.0144610280630133,0.163430851428954
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,35334,-0.0513615297152265,0.0253549966779049,-0.10105732320392,-0.00166573622653277,0.0428190047424982
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,35334,-0.0521067406423708,0.0253558866522349,-0.101804278480751,-0.00240920280399036,0.0399001123414602
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,35334,0.0645603031016188,0.0252708707098176,0.0150293965103763,0.114091209692861,0.0106397602254994
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,35334,-0.0851744260812055,0.0250372865104754,-0.134247507641737,-0.0361013445206737,0.000671469334369603
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,35334,-0.123040949035735,0.0256928528898727,-0.173398940699885,-0.0726829573715842,1.6978194292401e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20618.Liking for black olives,35334,-0.0333427920394188,0.0254183654565179,-0.0831627883341939,0.0164772042553563,0.189627430865605
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,35334,-0.101347975726606,0.0255687474975364,-0.151462720821777,-0.0512332306314346,7.4230899440313e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,35334,-0.0413307154316066,0.0253836119627906,-0.0910825948786761,0.0084211640154629,0.103500621762923
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,35334,-0.0625232992991305,0.025540449337256,-0.112582580000152,-0.0124640185981087,0.0143796141832874
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,35334,0.0273253307884249,0.0251555361701746,-0.0219795201051172,0.0766301816819671,0.277388960096667
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,35334,0.00248144976890381,0.0261376363021291,-0.0487483173832692,0.0537112169210768,0.924365888705305
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,35334,-0.00915897327373123,0.0251630283007833,-0.0584785087432665,0.040160562195804,0.715875672639156
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,35334,0.00625637317706398,0.0253272293455975,-0.0433849963403071,0.0558977426944351,0.80489591644677
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),35334,-0.0631314186468641,0.0250753604693067,-0.112279125166705,-0.0139837121270229,0.0118269947243552
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,35334,-0.103286036527275,0.0252086489616142,-0.152694988492039,-0.0538770845625116,4.20970865127761e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,35334,0.0454225967076928,0.0255482089006144,-0.00465189273751142,0.0954970861528971,0.0754439744474919
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,35334,0.0426254698707669,0.0254208549122313,-0.00719940575720646,0.0924503454987402,0.0936105498114801
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,35334,-0.00324047779392711,0.0253460747535273,-0.0529187843108406,0.0464378287229864,0.898270480470794
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20631.Liking for cake,35334,0.131020568740903,0.0255469429249262,0.0809485606080475,0.181092576873758,2.96637886988202e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,35334,0.0494847717405868,0.0251312199357261,0.000227580666563636,0.09874196281461,0.0489707410008276
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20633.Liking for capers,35334,-0.063599001461396,0.0254236566256512,-0.113429368447672,-0.0137686344751198,0.0123783031192228
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,35334,-0.00941299557062223,0.0256310950656219,-0.0596499418992412,0.0408239507579967,0.713440025739833
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,35334,0.021814619358522,0.0249985324692262,-0.0271825042811614,0.0708117429982054,0.382879787167929
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,35334,0.0641555479709049,0.0252844535812947,0.0145980189515673,0.113713076990243,0.0111826070545649
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20637.Liking for cherries,35334,0.000999701466081053,0.0263142005736326,-0.0505761316582389,0.052575534590401,0.969695559490145
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20638.Liking for chicken,35334,-0.0574664670153183,0.026318787525848,-0.10905129056598,-0.00588164346465631,0.0290209047509298
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,35334,-0.145988695689869,0.0253405941517013,-0.195656260227204,-0.096321131152535,8.57375271715746e-09
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,35334,-0.0294815147448144,0.0253687316902372,-0.0792042288576793,0.0202411993680505,0.245210846838186
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,35334,-0.0148541768946138,0.0396711429616023,-0.0926096170993544,0.0629012633101268,0.708089273354121
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20642.Liking for cod,35334,-0.00505537008137153,0.0256844180080627,-0.0553968293771744,0.0452860892144314,0.843966924045267
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,35334,0.00694946075770566,0.0275539576487862,-0.0470562962339152,0.0609552177493265,0.800881107348896
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,35334,0.058009726016075,0.0256061184301053,0.00782173389306861,0.108197718139081,0.0235028254001284
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20645.Liking for coriander,35334,-0.0693875729709271,0.0254129197609982,-0.119196895702484,-0.0195782502393707,0.00633531254719955
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,35334,0.04484819925139,0.0251293919456594,-0.00440540896210251,0.0941018074648824,0.0743378866556838
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20647.Liking for cream,35334,0.0514733913475738,0.0251854144121875,0.00210997909968631,0.100836803595461,0.0409983054111219
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20648.Liking for croissant,35334,0.030356860195072,0.0252880967892219,-0.019207809511803,0.079921529901947,0.229993038850013
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,35334,0.0134828672321572,0.0254420832829602,-0.0363836160024449,0.0633493504667592,0.596161351506492
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20650.Liking for curry,35334,-0.127948795183418,0.0256166784593477,-0.17815748496374,-0.0777401054030967,5.97810933898106e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,35334,0.067317418454125,0.0257013736726619,0.0169427260557076,0.117692110852542,0.0088248454770204
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,35334,0.0542087498798456,0.0252264392155392,0.00476492901738882,0.103652570742302,0.0316642864939573
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35334,-0.0403647887682313,0.0258125933534521,-0.0909574717409974,0.0102278942045348,0.117900741874307
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,35334,0.0446744588416271,0.025276837062725,-0.00486814180131386,0.0942170594845681,0.0771866875172341
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20655.Liking for eggs,35334,0.00197663265472632,0.0258415838978949,-0.0486728717851478,0.0526261370946004,0.939030299321517
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,35334,-0.000912018940233645,0.0251844504321036,-0.0502735417871567,0.0484495039066894,0.971112693667746
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,35334,-0.00309469932182443,0.0253023039030207,-0.0526872149717451,0.0464978163280962,0.902656453428898
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35334,-0.0600154286923407,0.0256135124980987,-0.110217913188614,-0.00981294419606723,0.0191404405248455
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,35334,-0.00805892018324048,0.0252547648652489,-0.0575582593191284,0.0414404189526474,0.749652752566487
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,35334,-0.0243018985455388,0.0267762393138331,-0.0767833276006518,0.0281795305095741,0.364112938509772
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,35334,-0.037391380135432,0.0249595224828343,-0.0863120442017872,0.0115292839309233,0.134139802690602
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,35334,-0.0142204598928326,0.0253475163152369,-0.0639015918706969,0.0354606720850316,0.574794966969483
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20663.Liking for fruit,35334,0.0273381186123109,0.0276119906526641,-0.0267813830669109,0.0814576202915326,0.322155223803406
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20664.Liking for garlic,35334,-0.0476989067426006,0.0256850166747679,-0.0980415394251457,0.0026437259399445,0.0633266408709286
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,35334,-0.0183995303042871,0.025222306926302,-0.067835251879839,0.0310361912712649,0.465714227675005
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,35334,-0.0462251083714674,0.0252913918792589,-0.0957962364548148,0.00334601971188002,0.0676203777795238
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,35334,0.00414151277560612,0.0252122458397923,-0.0452744890703868,0.0535575146215991,0.869524704273306
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,35334,0.08973996133798,0.0255533254729366,0.0396554434110244,0.139824479264936,0.000446676854024736
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,35334,-0.00904361185112931,0.0250707053897507,-0.0581821944150407,0.0400949707127821,0.718312226985902
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,35334,-0.246351356927599,0.0252733446052976,-0.295887112353982,-0.196815601501216,2.30949246639688e-22
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,35334,-0.045930717532949,0.0250060815952314,-0.0949426374596026,0.00308120239370455,0.0662679735610292
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20672.Liking for green olives,35334,-0.0323447284334177,0.0254273825557356,-0.0821823982426595,0.0174929413758241,0.203383579456053
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20673.Liking for haddock,35334,-0.0103737734822649,0.0255762939178983,-0.0605033095613456,0.0397557625968158,0.685043273800131
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20674.Liking for ham,35334,-0.0212914013022039,0.0252668901864332,-0.0708145060676129,0.0282317034632051,0.399436122292687
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,35334,-0.0133281613824521,0.0259586167640228,-0.0642070502399367,0.0375507274750325,0.607654295010973
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20676.Liking for herring,35334,0.0065758210392052,0.0250528731765327,-0.0425278103867988,0.0556794524652092,0.792957875918186
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20677.Liking for honey,35334,0.0391824058454859,0.0252166762837808,-0.0102422796707244,0.0886070913616963,0.120252785051809
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35334,-0.046055140784881,0.0251544996056753,-0.0953579600120046,0.00324767844224268,0.0671427902272887
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,35334,0.060988965611813,0.0254216336272459,0.011162563702411,0.110815367521215,0.0164514250712006
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20680.Liking for jam,35334,0.0293304101485553,0.0252576468439423,-0.0201745776655716,0.0788353979626821,0.245564941880405
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,35334,0.00492848924806435,0.0251545847854892,-0.0443744969314945,0.0542314754276232,0.84466993872104
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20682.Liking for lager,35334,-0.126609785779067,0.0252360802864339,-0.176072503140478,-0.0771470684176568,5.32670222800057e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20683.Liking for lamb,35334,-0.055453883942689,0.0252893199090703,-0.105020950964467,-0.00588681692091118,0.0283433427297627
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20684.Liking for lemons,35334,-0.0650578997626618,0.0253933738892461,-0.114828912585584,-0.0152868869397394,0.0104197075242754
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,35334,-0.0170046273652073,0.0254380886389624,-0.0668632810975735,0.032854026367159,0.503846374574553
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20686.Liking for liver,35334,0.0102863275868271,0.0254885716246379,-0.0396712727974632,0.0602439279711175,0.686539225230558
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,35334,-0.0148544595231414,0.0251813388607053,-0.0642098836901237,0.0345009646438409,0.555269645984947
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,35334,0.112134766468772,0.0251441721122667,0.0628521891287289,0.161417343808814,8.28658378840025e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,35334,-0.0330659278864427,0.0252151257666142,-0.0824875743890066,0.0163557186161212,0.189764830290594
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20690.Liking for melon,35334,-0.000723025182212682,0.0260977777006838,-0.051874669475553,0.0504286191111276,0.977898338186768
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,35334,-0.0266863510078471,0.0254374743052443,-0.0765438006461259,0.0231710986304317,0.294156078468552
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,35334,0.0310991818107242,0.0260306398095421,-0.0199208722159784,0.0821192358374267,0.232223324748288
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,35334,-0.024693765422867,0.0253168706338618,-0.0743148318652361,0.0249273010195021,0.329388538103352
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20695.Liking for oranges,35334,-0.00823609298254907,0.0256177195091367,-0.058446823220457,0.0419746372553589,0.747837486598019
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20696.Liking for pasta,35334,-0.0161988838542392,0.0256773953301017,-0.0665265787012385,0.03412881099276,0.528143567569059
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20697.Liking for pears,35334,0.04179405829971,0.0256041575031616,-0.00839009040648676,0.0919782070059068,0.10264054186062
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20698.Liking for pizza,35334,-0.0354671083037351,0.0253967587825005,-0.085244755517436,0.0143105389099658,0.162584679508114
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,35334,-0.00522741797878744,0.0252842592279273,-0.054784566065525,0.0443297301079501,0.836211947747236
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20700.Liking for plums,35334,0.0321170590224318,0.0254795239576558,-0.0178228079345736,0.0820569259794372,0.20751301571909
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20701.Liking for pollock,35334,-0.01330517586477,0.0252221562908555,-0.0627406021948468,0.0361302504653068,0.597843180355022
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,35334,-0.0199870446481435,0.0252285437308675,-0.0694349903606439,0.0294609010643569,0.428237530000848
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20703.Liking for porridge,35334,0.0725612102960913,0.025497577935605,0.0225859575423055,0.122536463049877,0.00443774759958886
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,35334,-0.0356979833531202,0.0253946994259726,-0.0854715942280265,0.014075627521786,0.159832670571732
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,35334,0.000182991123847503,0.02556635946253,-0.0499270734227112,0.0502930556704062,0.994289317469404
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20706.Liking for prawns,35334,-0.0460315731432292,0.0254212391872004,-0.095857201950142,0.00379405566368355,0.0702053317367327
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,35334,-0.00754219830054097,0.0254274070771278,-0.0573799161717115,0.0422955195706295,0.766764390731985
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20708.Liking for red meat,35334,-0.049036253145025,0.0253094604701751,-0.0986427956665682,0.000570289376518235,0.052712769932635
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20709.Liking for red wine,35334,-0.182122791392721,0.0253292211744523,-0.231768064894647,-0.132477517890794,6.87079072704882e-13
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35334,-0.0243840375290998,0.0259854480344553,-0.0753155156766321,0.0265474406184325,0.348072628507635
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,35334,-0.0472106665659188,0.0263240760694629,-0.098805855662066,0.00438452253022836,0.0729288471484358
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,35334,-0.0249222343724444,0.0251858669587961,-0.0742865336116847,0.0244420648667959,0.322423550291294
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,35334,-0.0244903390568971,0.0259052793238486,-0.0752646865316404,0.0262840084178462,0.344484711908601
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20714.Liking for salami,35334,-0.0482943916468764,0.0252730849619511,-0.0978296381723006,0.00124085487854782,0.0560420736989967
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20715.Liking for salmon,35334,-0.00124491965754425,0.0262866135719896,-0.0527666822586438,0.0502768429435553,0.962227568908966
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,35334,-0.028890124936113,0.0251828119822828,-0.0782484364213873,0.0204681865491612,0.251316297995389
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,35334,-0.026195876465444,0.0251398791510137,-0.0754700396014309,0.0230782866705429,0.297431393382601
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20718.Liking for sardines,35334,-0.024589463383025,0.0251756347827907,-0.0739337075572948,0.0247547807912449,0.32873002392737
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),35334,-0.0283474461119499,0.0251585374046206,-0.0776581794250062,0.0209632872011065,0.259870700714872
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,35334,-0.016478017814499,0.0255139760800225,-0.0664854109313432,0.0335293753023452,0.518394090754145
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35334,-0.0444470734704234,0.02527942579124,-0.0939947480212538,0.00510060108040696,0.0787348687884616
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,35334,-0.0330726210817171,0.0251969957876361,-0.0824587328254838,0.0163134906620496,0.189356830150004
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,35334,-0.00858420075001472,0.0254961614770041,-0.0585566772449427,0.0413882757449133,0.736359776793612
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,35334,-0.0406594429946479,0.0253129965174552,-0.0902729161688601,0.00895403017956438,0.108242692808972
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,35334,-0.0589982433321184,0.0252815162768815,-0.108550015234806,-0.00944647142943054,0.0196311797824103
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,35334,0.0379049839471463,0.0252314425546226,-0.0115486434599139,0.0873586113542066,0.133049360688707
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,35334,-0.117711701928215,0.0254746601247977,-0.167642035772819,-0.0677813680836114,3.86548052315372e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20728.Liking for spinach,35334,-0.00743347059080858,0.0255798701038983,-0.0575700159944492,0.0427030748128321,0.771363702162
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20729.Liking for spirits,35334,-0.192523871943013,0.0251341639461977,-0.241786833277561,-0.143260910608466,2.011228627529e-14
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,35334,-0.0238542484922622,0.0274434860980168,-0.0776434812443751,0.0299349842598506,0.384748562747235
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35334,-0.0343582164147507,0.0258099381318453,-0.0849456951531675,0.0162292623236661,0.183149339480112
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,35334,0.0736783758628277,0.0252429042950563,0.0242022834445174,0.123154468281138,0.00352092238149891
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,35334,-0.0270737130917079,0.0258387052891849,-0.0777175754585102,0.0235701492750944,0.294754318295501
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,35334,-0.00274359569608552,0.0304230617732428,-0.0623727967716414,0.0568856053794703,0.928144603681906
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,35334,0.0546653263028945,0.0263997012689895,0.00292191181567513,0.106408740790114,0.038411063521161
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,35334,-0.00404194966064061,0.0249377996007032,-0.0529200368780189,0.0448361375567377,0.871244729743598
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,35334,-0.03235454517756,0.0253944442738108,-0.0821276559542291,0.0174185655991091,0.202661007966137
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),35334,0.0233153869792512,0.0250128754527229,-0.0257098489080858,0.0723406228665881,0.351286177213068
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,35334,0.0267262789271005,0.0276721237310061,-0.0275110835856714,0.0809636414398724,0.33415484054579
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,35334,-0.0527646864105373,0.0251150228095119,-0.101990131117181,-0.00353924170389398,0.0356696518693077
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20741.Liking for watching television,35334,-0.0228383958576071,0.0253438944564006,-0.0725124289921523,0.0268356372769381,0.367532841491388
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20742.Liking for whisky,35334,-0.106089725314075,0.0260888833837131,-0.157223936746152,-0.0549555138819971,4.80492142902543e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20743.Liking for white bread,35334,-0.0253619172933356,0.0252012368194774,-0.0747563414595113,0.0240325068728402,0.314256022717049
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20744.Liking for white rice,35334,-0.0057207864394304,0.0252952044535899,-0.0552993871684666,0.0438578142896058,0.821080304403013
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20745.Liking for white wine,35334,-0.162080726321741,0.0252255170499702,-0.211522739739683,-0.1126387129038,1.36852117685525e-10
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35334,0.0411819678571881,0.0255381489069197,-0.00887280400037448,0.0912367397147507,0.106866206984501
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,35334,0.0491384886739056,0.0250685170797638,4.19519756864745e-06,0.0982727821502426,0.0500004172970928
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,35334,-0.0353453613104184,0.0262433984349331,-0.0867824222428873,0.0160916996220505,0.178062041413767
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,35334,-0.0501980048185788,0.0251899619348303,-0.0995703302108462,-0.000825679426311413,0.0463094147645113
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21001.Body mass index (BMI),51848,-0.240800577806228,0.0167878742000645,-0.273704811238355,-0.207896344374102,1.70534110745762e-46
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21002.Weight,51869,-0.0768837739181169,0.00972743274572842,-0.0959495420997446,-0.0578180057364893,2.80390649372906e-15
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32963,-0.0197454466828367,0.00780835497326265,-0.0350498224304315,-0.00444107093524192,0.0114634168328943
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34699,-0.00717686621336685,0.0271255515054651,-0.0603429471640785,0.0459892147373448,0.791338408521477
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34698,-0.0836060414731799,0.0282728493857714,-0.139020826269292,-0.028191256677068,0.00311203186587104
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34698,0.0243519538568595,0.0278231495900856,-0.0301814193397083,0.0788853270534272,0.381462335092762
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,34668,0.0472349083562119,0.025962437833429,-0.00365146979730892,0.0981212865097327,0.0688848638147585
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34666,0.0589847919038996,0.0274838030227727,0.00511653797926512,0.112853045828534,0.031881991110715
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34657,-0.03890400363091,0.0280741269685809,-0.0939292924893285,0.0161212852275086,0.165848808681149
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,34601,-0.0275405896051015,0.0276689305494498,-0.081771693482023,0.02669051427182,0.319582876593989
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,34629,-0.00345773129575468,0.0310506290572781,-0.0643169642480197,0.0574015016565104,0.911334659709722
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34703,0.023872057767549,0.0282006608555768,-0.0314012375093816,0.0791453530444796,0.397288635019794
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34698,0.0389745542616885,0.0283795461161572,-0.0166493561259796,0.0945984646493565,0.169677401105664
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30187,-0.0629456751922528,0.041634275967247,-0.144548856088057,0.0186575057035512,0.130616506781462
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34701,-0.070644758008073,0.0297762554046542,-0.129006218601195,-0.0122832974149508,0.0176845614291022
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34698,-0.0621761399747747,0.0426329242588205,-0.145736671522063,0.0213843915725135,0.144757470679636
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34701,-0.0067765174257655,0.0335763210597745,-0.0725861067029235,0.0590330718513925,0.840057872548621
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34700,-0.0634806739672231,0.0824400046380401,-0.225063083057782,0.0981017351233355,0.441303216012036
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34701,0.0062746125871805,0.0317905861163093,-0.0560349362007858,0.0685841613751468,0.843539130215657
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34701,-0.0815297726786813,0.0332199957854499,-0.146640964418163,-0.0164185809391994,0.0141339663013859
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34459,0.0688999934807253,0.0294741132145663,0.0111307315801753,0.126669255381275,0.0194242189922076
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34701,-0.0223427036282986,0.0294759104175495,-0.0801154880466957,0.0354300807900985,0.448468201472408
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34702,-0.0698357707709028,0.0405037839418099,-0.14922318729685,0.00955164575504466,0.0847040541950093
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34700,-0.0209390871233771,0.0281198511689485,-0.0760539954145162,0.034175821167762,0.456507219446709
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34698,0.0487722726672402,0.028186027233588,-0.00647234071059227,0.104016886045073,0.083592552469802
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),51614,0.0148750393373492,0.0171641919720039,-0.0187667769277785,0.0485168556024768,0.386151124779363
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48943,0.0216899271960836,0.004468675689171,0.0129313228453085,0.0304485315468588,1.21863624205952e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,46937,-0.0619844047370452,0.0193179911270764,-0.099847667346115,-0.0241211421279755,0.00133548329108404
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22032.IPAQ activity group,46899,0.0246513158781248,0.0186595270181202,-0.0119213570773908,0.0612239888336404,0.186477307551723
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22033.Summed days activity,47475,0.00138408587599296,0.00431220382063826,-0.00706783361245803,0.00983600536444396,0.748236349743998
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22034.Summed minutes activity,46899,-0.00298050273392709,0.00440808686200329,-0.0116203529834535,0.00565934751559935,0.49895583019471
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22037.MET minutes per week for walking,46125,-0.00547970637985702,0.00431714713800796,-0.0139413147703526,0.00298190201063858,0.204351357782026
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,46899,0.000344899714805727,0.00451546441533593,-0.00850541053925269,0.00919520996886415,0.939115938923113
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,46899,-0.00665844136713203,0.0186794012868008,-0.0432700678892616,0.0299531851549975,0.721500089211984
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,46125,-7.3461955477608e-05,0.00444530382370942,-0.00878625744994808,0.00863933353899286,0.986815111775565
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,46265,0.00200347191034218,0.00515861535177217,-0.00810741417913127,0.0121143579998156,0.697742996409201
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X22501.Year ended full time education,31362,0.0301252315024941,0.0216241349420261,-0.0122580729838771,0.0725085359888653,0.163621754011155
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,31312,0.0568827480366284,0.0675595512450237,-0.0755339724036181,0.189299468476875,0.399834815736024
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49933,-0.122647479743168,0.0371509890267752,-0.195463418235647,-0.0498315412506884,0.000963586804664278
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23098.Weight,51496,-0.0743464079669697,0.00979556119236631,-0.0935457079040077,-0.0551471080299317,3.30475862766899e-14
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23099.Body fat percentage,51475,-0.130775020373832,0.00948854132687401,-0.149372561374505,-0.112177479373159,4.51712474225741e-43
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23100.Whole body fat mass,51439,-0.137194144974472,0.0090133771948096,-0.154860364276299,-0.119527925672645,4.16916414548354e-52
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51492,-0.000513428311186952,0.00837675054780279,-0.0169318593848804,0.0159050027625065,0.951127056070209
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23102.Whole body water mass,51496,0.000559553789410335,0.00837713831452348,-0.0158596373070557,0.0169787448858764,0.946745117643691
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23104.Body mass index (BMI),51496,-0.241601358623651,0.0169181066057284,-0.274760847570879,-0.208441869676423,4.21697836472088e-46
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23105.Basal metabolic rate,51494,-0.012219308495252,0.00897592316802557,-0.0298121179045822,0.00537350091407808,0.173416478872753
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23106.Impedance of whole body,51493,-0.0496308893309803,0.00689232614188712,-0.0631398485690791,-0.0361219300928816,6.13484748431304e-13
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23107.Impedance of leg (right),51493,-0.08235610802267,0.00566304445756325,-0.0934556751594939,-0.071256540885846,9.7522034112122e-48
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23108.Impedance of leg (left),51492,-0.0812882642302274,0.00562250876285053,-0.0923083814054144,-0.0702681470550403,3.33676847234176e-47
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23109.Impedance of arm (right),51486,0.00984290335602169,0.00692120948161264,-0.00372266722793908,0.0234084739399825,0.154997971735685
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23110.Impedance of arm (left),51491,0.00705712566540529,0.00690714279558289,-0.00648087421393718,0.0205951255447477,0.306925147870005
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51492,-0.215166159367702,0.0117289628195595,-0.238154926494038,-0.192177392241365,1.00880651729331e-74
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23112.Leg fat mass (right),51491,-0.208916856613747,0.0121649011374367,-0.232760062843123,-0.185073650384371,9.17234295698464e-66
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51491,0.0418441304495327,0.00900709719298608,0.02419021995128,0.0594980409477854,3.40512374785542e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51490,0.0431034746806433,0.00904136509692665,0.0253823990906671,0.0608245502706195,1.87602099690036e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51489,-0.224445814262085,0.0120974798019835,-0.248156874673973,-0.200734753850197,2.24290993765123e-76
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23116.Leg fat mass (left),51489,-0.217622202219809,0.0126341803792237,-0.242385195763087,-0.192859208676531,3.83103419237638e-66
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51488,0.0317941558229021,0.00934222116157407,0.0134834023462169,0.0501049092995872,0.0006667749151619
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51487,0.0309946308666991,0.00937858860261022,0.0126125972055831,0.0493766645278152,0.00095155323302518
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51487,-0.0858335660121131,0.0104780646053251,-0.10637057263855,-0.0652965593856759,2.68493655039701e-16
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23120.Arm fat mass (right),51484,-0.116583536294527,0.0102483621602901,-0.136670326128695,-0.0964967464603582,6.43305488862583e-30
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51484,-0.0338492575964912,0.00838277724535225,-0.0502795009973817,-0.0174190141956008,5.40651940415817e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51483,-0.0326271483400086,0.0083900836297002,-0.0490717122542211,-0.0161825844257962,0.000100987137173423
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51479,-0.0884619274578011,0.0107060019145179,-0.109445691210256,-0.067478163705346,1.48555182097494e-16
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23124.Arm fat mass (left),51478,-0.118506999441149,0.0102046784757237,-0.138508169253568,-0.0985058296287308,4.18081396177266e-31
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51475,-0.0345408429530407,0.00851913821562289,-0.0512383538556615,-0.0178433320504198,5.03794276422281e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51474,-0.0345794003996494,0.00856407956242494,-0.0513649963420023,-0.0177938044572965,5.41176333973454e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23127.Trunk fat percentage,51471,-0.0756754156284328,0.00681473992252979,-0.0890323058765911,-0.0623185253802744,1.36883087564138e-28
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23128.Trunk fat mass,51467,-0.0955862595757282,0.00742653772285051,-0.110142273512515,-0.0810302456389412,8.43121648290869e-38
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51461,-0.0116024517374947,0.00763158632912975,-0.026560360942589,0.00335545746759962,0.128442076969448
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23130.Trunk predicted mass,51459,-0.0114375209790003,0.00762015442313748,-0.0263730236483498,0.00349798169034917,0.133378230124873
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,39749,-0.177824911444621,0.00555279332897904,-0.18870838636942,-0.166941436519822,4.01391524885137e-218
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39749,-0.199159022394322,0.00533904402329744,-0.209623548679985,-0.188694496108659,5.01496863286632e-292
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39749,-0.182101810633758,0.00540436743593084,-0.192694370808183,-0.171509250459334,1.80280439779547e-240
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,39749,-0.181466758600539,0.00532523614440624,-0.191904221443575,-0.171029295757502,1.03791397748242e-245
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39749,-0.199189462468385,0.00533375587319193,-0.209643623979841,-0.188735300956928,1.15771303528002e-292
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,39749,-0.205937639577227,0.00526806636275099,-0.216263049648219,-0.195612229506235,1.66880539388825e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,39749,0.0278124491132887,0.00628275460610005,0.0154982500853326,0.0401266481412448,9.62822240711779e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,39749,-0.138413749709009,0.0055498804082753,-0.149291515309229,-0.12753598410879,1.0555901241781e-134
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,39749,-0.141733071976467,0.0056368634105861,-0.152781324261216,-0.130684819691718,7.68476302247457e-137
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,39749,-0.144784961860746,0.00528119534996457,-0.155136104746677,-0.134433818974816,1.02245103199034e-161
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,39749,-0.0666184930196553,0.00531444220563356,-0.0770347997426971,-0.0562021862966136,7.06802000133592e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39749,-0.142052856482354,0.0055572781628449,-0.15294512168153,-0.131160591283178,2.87908418483163e-141
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,39749,-0.174403016495692,0.00540248846549655,-0.184991893888065,-0.163814139103319,1.67230635129424e-221
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,39749,-0.208889707867553,0.00526779611818583,-0.219214588259197,-0.198564827475908,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,39749,0.0206029243950684,0.00590163662506253,0.00903571660994585,0.0321701321801909,0.000482426945575373
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,39749,-0.175518801131203,0.00557817385189655,-0.18645202188092,-0.164585580381486,7.23502019956823e-211
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39749,-0.177947671143958,0.00533204469803583,-0.188398478752108,-0.167496863535808,4.36635669535715e-236
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39749,-0.210217471534122,0.00523586827536217,-0.220479773353832,-0.199955169714412,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39749,0.0297710951626046,0.00627128501278393,0.0174793765375481,0.0420628137876611,2.08041788432451e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,39749,-0.179783741913259,0.0054933372328453,-0.190550682889636,-0.169016800936882,2.08596689064054e-227
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39749,-0.182283157732139,0.00535693444245533,-0.192782749239352,-0.171783566224927,4.9592095772258e-245
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,39749,-0.187314712145873,0.0053817023571512,-0.197862848765889,-0.176766575525856,7.24011380423688e-256
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,39749,0.0207814466865079,0.00623154289492669,0.00856762261245154,0.0329952707605642,0.000855315827918205
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39749,-0.177601159103181,0.00534926129490756,-0.1880857112412,-0.167116606965162,9.31502501325677e-234
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,39749,-0.167104179173275,0.00547041303621257,-0.177826188724252,-0.156382169622298,3.40794911400752e-199
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,39749,-0.209302107690164,0.00525377116593308,-0.219599499175393,-0.199004716204935,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,39749,0.0179451552613135,0.00603135998978668,0.00612368968133166,0.0297666208412954,0.00293134547745094
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39749,-0.114826142611477,0.00561386021042755,-0.125829308623915,-0.103822976599039,8.39028630221973e-92
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,39749,-0.175636680755451,0.00532623973793958,-0.186076110641813,-0.16519725086909,1.00268928402125e-230
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,39749,-0.198630177234063,0.00529699120415132,-0.2090122799942,-0.188248074473927,5.85629767832217e-295
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,39749,-0.0866619014511945,0.00564756517884834,-0.0977311292017373,-0.0755926737006518,9.14203709578113e-53
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39749,-0.140569302042522,0.00593662863673391,-0.15220509417052,-0.128933509914523,7.70657047517519e-122
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39749,0.0039850711007181,0.00550864140536921,-0.00681186605380555,0.0147820082552418,0.469431451409786
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39749,0.190090266606281,0.00621635224504921,0.177906216205984,0.202274317006577,1.34530293520879e-199
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,39738,-0.11584246431248,0.00553039411701406,-0.126682036781827,-0.105002891843132,4.01448676979366e-96
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39738,-0.109454013345645,0.00599169813628452,-0.121197741692762,-0.0977102849985269,8.53475531270088e-74
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23436.Total Cholines,39738,-0.120972658437369,0.00561832020886899,-0.131984566046752,-0.109960750827986,2.19940443107846e-101
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,39738,-0.109726045002644,0.00561928900311941,-0.120739851448758,-0.0987122385565301,6.27336321027336e-84
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,39737,-0.136227127251136,0.00577996775404344,-0.147555864049062,-0.124898390453211,9.44702822706228e-121
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,39749,-0.194752797832354,0.00532612557090013,-0.205192003951319,-0.18431359171339,3.91107022911254e-281
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,39749,-0.0226880023206176,0.00586144586959272,-0.0341764362250193,-0.0111995684162159,0.00010894932710053
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39749,-0.156608672099143,0.00540822984375028,-0.167208802592893,-0.146008541605392,1.01700847316792e-179
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,39738,-0.150046812810984,0.00526462425258864,-0.160365476346058,-0.13972814927591,2.70071334487696e-174
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,39738,0.0336159207777592,0.00597795681831091,0.0218991254138698,0.0453327161416486,1.90485491462893e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39738,-0.0757990088266923,0.00545365414395323,-0.0864881709488406,-0.0651098467045439,1.16138051253144e-43
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39738,-0.145794673466218,0.0053474108321418,-0.156275598697216,-0.13531374823522,5.28195300525437e-160
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39738,-0.143082599398259,0.00535789361132029,-0.153584070876447,-0.132581127920072,1.00252327662945e-153
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39738,-0.134070476686425,0.00539056192800794,-0.144635978065321,-0.12350497530753,5.50376345703297e-134
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,39738,-0.155012740681826,0.00528480433848763,-0.165370957185262,-0.144654524178391,3.22081424695978e-184
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,39738,-0.130014139384549,0.00541398409270788,-0.140625548206257,-0.119402730562842,3.3188873605058e-125
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,39738,-0.0670707841863851,0.00570372217655234,-0.0782500796524277,-0.0558914887203426,8.58760361998969e-32
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39738,-0.00314985852238507,0.00554780268409684,-0.0140235517832149,0.00772383473844474,0.570201311680307
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39738,0.0900795334887093,0.00560853156658039,0.0790868116182117,0.101072255359207,1.35719776536828e-57
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39738,0.0970981383421256,0.00583430623903515,0.0856628981136167,0.108533378570634,1.13954490734912e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39738,-0.0627517367953239,0.005984382166767,-0.0744811258421873,-0.0510223477484606,1.21603301797336e-25
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39738,-0.0862348374488566,0.00537361323269213,-0.0967671193849332,-0.0757025555127801,1.67671031477402e-57
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39738,0.0403158383006557,0.00577578008150765,0.0289953093409007,0.0516363672604107,3.06526358361707e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39738,0.0331511358649636,0.00579340048036499,0.0217960709234482,0.0445062008064789,1.07034792313986e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39738,0.0826178633829607,0.00596814605405633,0.0709202971170103,0.0943154296489111,2.4987325428284e-43
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39736,0.0247760041281529,0.00549896114081522,0.0139980402921551,0.0355539679641508,6.66645964188438e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23460.Alanine,39746,0.0251124111326401,0.00534385352836508,0.0146384582170446,0.0355863640482356,2.63234139060236e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23461.Glutamine,39708,0.0756878997239682,0.00526186912262746,0.0653746362436183,0.086001163204318,1.27793923240461e-46
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23462.Glycine,39730,0.0904521406262459,0.00551101722442284,0.0796505468663772,0.101253734386115,4.82412415722235e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23463.Histidine,39732,0.0281405060204689,0.00527733009528519,0.01779693903371,0.0384840730072279,9.8284235583283e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39738,0.0553908737078841,0.00561453362830705,0.0443863877964023,0.0663953596193659,6.82720962659872e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23465.Isoleucine,39747,0.0948425467931024,0.00543876558841785,0.0841825662398034,0.105502527346401,1.79595744946637e-67
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23466.Leucine,39748,0.0373244224258412,0.00566069993996066,0.0262294505435183,0.0484193943081641,4.42805074961694e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23467.Valine,39738,0.0471700546159601,0.00559373653166477,0.0362063310138971,0.058133778218023,3.66636848654835e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23468.Phenylalanine,39746,0.0982517198168461,0.00527346043177445,0.0879157373705682,0.108587702263124,1.17251306177785e-76
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23469.Tyrosine,39733,0.0890965183744505,0.00540877398823053,0.0784953213575187,0.0996977153913824,1.83292472435769e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23470.Glucose,39723,0.0104971452546574,0.00544867046947492,-0.00018224886551341,0.0211765393748283,0.0540533690736037
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23471.Lactate,39721,-0.048547588922008,0.00533880757849938,-0.0590116517758668,-0.0380835260681492,1.07208872647794e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23472.Pyruvate,39705,-0.00532087521340474,0.00528715354203721,-0.0156836961557977,0.0050419457289882,0.314249121543272
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23473.Citrate,39748,0.0220896497199921,0.00540233557430217,0.0115010719943598,0.0326782274456243,4.35543468269011e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,39496,-0.0896100369531489,0.00519993654798796,-0.0998019125872053,-0.0794181613190925,6.11020512255044e-66
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23475.Acetate,39735,0.0380120148524068,0.00534351976967177,0.0275387161038501,0.0484853136009634,1.17826271049622e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23476.Acetoacetate,39749,-0.0145281654199496,0.0052315176166951,-0.024781939948672,-0.00427439089122726,0.00549196676160436
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23477.Acetone,39749,-0.000936557097055231,0.00527052308490432,-0.0112667823434677,0.00939366814935724,0.858963064076275
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23478.Creatinine,39327,0.0180537278900358,0.00662511139674931,0.00506850955240717,0.0310389462276645,0.00643649763342368
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23479.Albumin,39749,-0.0437582112103473,0.00540696494728319,-0.0543558625070223,-0.0331605599136722,6.24271032499004e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,39749,-0.0719148737324617,0.00566517849152871,-0.083018623575858,-0.0608111238890655,9.60398709760569e-37
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39749,-0.0928020228841587,0.00566787811483102,-0.103911063989227,-0.0816929817790899,9.149018547632e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39749,-0.0875764685990992,0.00569757354136914,-0.0987437127401827,-0.0764092244580157,6.17366811825215e-53
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39749,-0.0956283744551525,0.00569562392946885,-0.106791797356911,-0.0844649515533935,1.00607386384049e-62
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39749,-0.119045816960086,0.00562360353488082,-0.130068079888452,-0.10802355403172,4.16125475824714e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39749,-0.132809441042614,0.00562928767708435,-0.1438428448897,-0.121776037195529,5.47514419590465e-121
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39749,-0.0968147876515976,0.0056023063983237,-0.107795308192312,-0.0858342671108831,2.62880127721157e-66
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39749,-0.067591983569777,0.00570173986575778,-0.0787673937066622,-0.0564165734328917,2.78561396941726e-32
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39749,-0.157220412429494,0.00568475265102197,-0.168362527625497,-0.146078297233491,1.78477599849089e-164
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39749,-0.152902152636768,0.00569905532107548,-0.164072301066076,-0.14173200420746,4.10604465529843e-155
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39749,-0.15325092761331,0.00565873755106768,-0.164342053213403,-0.142159802013218,6.02006854595615e-158
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39749,-0.177528980773414,0.00552624170134517,-0.18836041450805,-0.166697547038777,1.94935399100699e-219
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39749,-0.191373015206879,0.00544306796297678,-0.202041428414314,-0.180704601999445,7.4740394356177e-261
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39749,-0.155764342444929,0.0056089935281988,-0.166757969760199,-0.14477071512966,8.74187638956493e-166
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39749,-0.137740119039005,0.00577582809388445,-0.149060742103019,-0.126419495974992,1.56987229743681e-123
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39749,-0.166560951816036,0.00560576434733692,-0.177548249936816,-0.155573653695256,7.45869571531991e-189
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39749,-0.166608420836783,0.00561242577882997,-0.17760877536329,-0.155608066310276,1.58716597282765e-188
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39749,-0.168123111963311,0.00563872003761861,-0.179175003237044,-0.157071220689579,4.03091139023006e-190
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39749,-0.178177587743276,0.0054869262566756,-0.18893196320636,-0.167423212280192,5.00746790568602e-224
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39749,-0.174629558812394,0.00539945428464881,-0.185212489210305,-0.164046628414482,2.6991028204172e-222
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39749,-0.178989421828693,0.0055911425781927,-0.18994806128195,-0.168030782375435,5.65335981563288e-218
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39749,-0.153404816824008,0.00566892377259948,-0.164515907418303,-0.142293726229713,1.05134842023945e-157
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39749,-0.195012282755887,0.00528702694712289,-0.205374855572248,-0.184649709939526,7.79486624089522e-286
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39749,-0.189556479275036,0.00532282024376209,-0.19998920695281,-0.179123751597263,2.60207847684516e-267
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39749,-0.191596167973434,0.00529363440560168,-0.201971691408414,-0.181220644538455,1.04723815537569e-275
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39749,-0.177764757776771,0.00537841275916814,-0.188306446784741,-0.167223068768801,9.62345502224785e-232
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39749,-0.159259673128612,0.00548171396687199,-0.170003832503681,-0.148515513753543,7.31782170473155e-181
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39749,-0.18972207966666,0.00529552458495957,-0.200101307853181,-0.179342851480139,2.12799832502142e-270
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39749,-0.168100990406337,0.00551409794578117,-0.178908622380068,-0.157293358432605,1.99466458993199e-198
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39749,-0.174456086337529,0.00535713547954835,-0.184956071877444,-0.163956100797615,3.015567373337e-225
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39749,-0.179464700428264,0.00533190568037799,-0.189915235561805,-0.169014165294724,5.71348763585393e-240
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39749,-0.193953542203911,0.00526106743117774,-0.204265234369019,-0.183641850038802,1.49916475086333e-285
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39749,-0.193466971080355,0.00527212978766402,-0.203800345464177,-0.183133596696534,4.73096213454223e-283
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39749,-0.189794498033553,0.00529007478206354,-0.200163044606397,-0.179425951460708,3.96767488673421e-271
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39749,-0.196333953020521,0.00526739345367822,-0.20665804418973,-0.186009861851312,1.35276317772814e-291
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39749,-0.125634011563813,0.00549775223184966,-0.136409605938239,-0.114858417189388,9.47577265552468e-114
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39749,-0.138712559483338,0.00541078443622008,-0.14931769697833,-0.128107421988347,4.57302164088302e-142
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39749,-0.128809340242925,0.00540897057840032,-0.139410922576589,-0.11820775790926,3.41052170247953e-123
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39749,-0.123003972954612,0.00538463894508164,-0.133557865286972,-0.112450080622252,1.14126911941486e-113
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39749,-0.125000072566064,0.00562234337585384,-0.136019865582738,-0.113980279549391,7.27342623342449e-108
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39749,-0.116769148048859,0.00570946031371794,-0.127959690263746,-0.105578605833972,8.76240098936871e-92
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39749,-0.137638303237433,0.00543773855564953,-0.148296270806506,-0.12698033566836,1.3062954534414e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39749,-0.103935554909656,0.00536221132972305,-0.114445489115913,-0.0934256207033985,9.68144493771117e-83
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,39749,-0.157318884819018,0.00553192069243484,-0.16816144937619,-0.146476320261846,1.46397498115462e-173
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,39749,-0.158145043891944,0.00565792794699616,-0.169234582668056,-0.147055505115831,7.17128648683873e-168
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,39749,-0.152532400391892,0.0056663808418682,-0.163638506841954,-0.14142629394183,4.10570798218232e-156
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,39749,-0.151662151642769,0.00570550628080034,-0.162844943953137,-0.1404793593324,2.3246211136129e-152
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39749,-0.1497507749423,0.00569928143670799,-0.160921366558248,-0.138580183326352,5.4850900008988e-149
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,39749,-0.152374708776747,0.00570641285220005,-0.163559277967059,-0.141190139586434,1.06715869156563e-153
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,39749,-0.110605817428755,0.00528019089412801,-0.120954991581246,-0.100256643276264,3.9411781433464e-96
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39749,-0.187583299582948,0.00533014797496477,-0.198030389613879,-0.177136209552017,2.47381762780932e-261
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,39749,-0.198926746367374,0.00532214700772145,-0.209358154502508,-0.18849533823224,3.84183772094203e-293
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,39749,-0.200740240753722,0.00533914380542296,-0.211204962612351,-0.190275518895093,1.91182690340104e-296
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,39749,-0.194112829633882,0.00534238395784382,-0.204583902191256,-0.183641757076508,9.34159513216775e-278
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39749,-0.197517985834638,0.00530154692589824,-0.207909017809399,-0.187126953859877,2.40553981953286e-291
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39749,-0.179431811059905,0.00547252943678532,-0.190157968756004,-0.168705653363806,3.29043534082267e-228
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,39749,-0.142033120035127,0.00525277170805977,-0.152328552582925,-0.13173768748733,1.81131320562179e-157
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39749,-0.208653464195774,0.00524684848760721,-0.218937287231484,-0.198369641160064,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39749,-0.225342613660119,0.00517203637826168,-0.235479804961512,-0.215205422358726,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39749,-0.221952495236812,0.00517072637456195,-0.232087118930953,-0.211817871542671,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39749,-0.224101537187102,0.00517742117208419,-0.234249282684387,-0.213953791689817,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39749,-0.227639458618373,0.00517668871871434,-0.237785768507053,-0.217493148729693,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39749,-0.201251427440204,0.00523608221285372,-0.211514148577398,-0.190988706303011,1.76735563471856e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39749,-0.153417962412748,0.00531202450524206,-0.163829530443022,-0.143006394382473,8.27458414893976e-179
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39749,-0.193371579663878,0.00530822531649626,-0.203775701284211,-0.182967458043546,3.94326130831146e-279
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,39749,-0.20994316713576,0.00525361157225738,-0.220240245817385,-0.199646088454136,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,39749,-0.189431786445066,0.00531279021703406,-0.199844855270453,-0.179018717619679,6.13344602952747e-268
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,39749,-0.213261559717779,0.00523703155453551,-0.223526141564668,-0.202996977870889,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39749,-0.217286888434568,0.00522937154095258,-0.227536456654835,-0.207037320214301,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39749,-0.181799582784631,0.00529862982066445,-0.192184897233134,-0.171414268336129,5.99359524079813e-249
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,39749,-0.128447376327534,0.00542634786850663,-0.139083018149807,-0.117811734505261,9.09901243380359e-122
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39749,0.116144251331696,0.00637921012638923,0.103640999483973,0.128647503179419,2.53963273990243e-73
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39749,0.15776037150799,0.00634049100793563,0.145333009132436,0.170187733883544,4.30509275381914e-134
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39749,0.178417756674174,0.00623020699221458,0.166206550969433,0.190628962378914,6.52797388077259e-176
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39749,0.137171231451434,0.00647220760682586,0.124485704542055,0.149856758360813,2.48712050980175e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39749,0.133316675041529,0.00655809273551271,0.120462813279924,0.146170536803134,1.02133716506468e-90
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39749,0.139503725293389,0.00607613337405717,0.127594503880237,0.151412946706541,8.71673380353554e-115
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39749,-0.0262127949072461,0.00524735595616458,-0.0364976125813287,-0.0159279772331635,5.93283122473368e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39749,0.124872214267053,0.00652133351787617,0.112090400572015,0.13765402796209,8.12810546871191e-81
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,39749,0.135822028980658,0.00640573269830174,0.123266792891987,0.14837726506933,2.05176403208133e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,39749,0.133254569071078,0.00626953078180627,0.120966288738737,0.145542849403418,7.12642181509171e-99
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,39749,0.139403466963952,0.00656393434906552,0.126538155639784,0.152268778288121,1.00330743207481e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39749,0.139374559660866,0.00657698125715101,0.12648367639685,0.152265442924882,2.62543450993796e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39749,0.13662729265616,0.00647702209571914,0.123932329348551,0.14932225596377,1.94286743378847e-97
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,39749,0.0244572213446689,0.00529278365893048,0.0140833653731651,0.0348310773161726,3.85152365224343e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39749,-0.0100899342820001,0.00579807164814257,-0.0214541547123596,0.00127428614835928,0.0818393305358496
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39749,-0.0115295665819965,0.00570389919274354,-0.0227092089997738,-0.000349924164219131,0.0432604618871688
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39749,-0.0111958572380884,0.00560958748286754,-0.0221906487045088,-0.000201065771668027,0.0459680287370095
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39749,-0.00102171342994246,0.00588864701462187,-0.0125634615786013,0.0105200347187164,0.862256210483224
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39749,0.00054947602133272,0.00587812455861756,-0.0109716481135577,0.0120706001562231,0.925524911455571
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39749,-0.00735961614725297,0.0059010175852147,-0.0189256106142738,0.00420637831976785,0.212350816943925
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39749,-0.0662250378226039,0.00533061270452687,-0.0766730387234766,-0.0557770369217312,2.84019430467204e-35
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39749,-0.190085553563132,0.00508108758302286,-0.200044485225856,-0.180126621900407,1.22447131109961e-293
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,39749,-0.166023690032575,0.00515848459034482,-0.176134319829651,-0.155913060235499,3.19330031072747e-220
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,39749,-0.141019033449246,0.00521303852253264,-0.15123658895341,-0.130801477945082,1.34265428105856e-157
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,39749,-0.177257533339972,0.00510458326870358,-0.187262516546632,-0.167252550133313,9.83214347568941e-255
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39749,-0.17359453911243,0.00509520567709871,-0.183581142239543,-0.163607935985316,1.27933273466457e-245
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39749,-0.163638327515068,0.00521768570981675,-0.173864991506309,-0.153411663523827,1.52858670446257e-209
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,39749,-0.140365361814238,0.00565766910000226,-0.151454393250242,-0.129276330378233,2.39614837739434e-133
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38987,-0.0275051963191713,0.00538639273350143,-0.0380625260768341,-0.0169478665615085,3.32303098599301e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38987,-0.0552550607837867,0.00536424531004261,-0.0657689815914702,-0.0447411399761032,8.45439198387187e-25
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38987,-0.0782602060808402,0.00529771408398143,-0.0886437256854438,-0.0678766864762366,4.84365883692304e-49
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38987,0.000417903472056868,0.00547155197833267,-0.0103063384054752,0.0111421453495889,0.939119778196086
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38987,0.0566447279501698,0.00525717599481903,0.0463406630003245,0.066948792900015,5.67590071663599e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39557,-0.0627450582117035,0.00520402367067616,-0.0729449446062287,-0.0525451718171782,2.49990306494024e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39557,0.0033641029362678,0.00583053500139281,-0.0080637456664621,0.0147919515389977,0.563961141875353
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39557,-0.00108025035658858,0.00580630587065039,-0.0124606098630633,0.0103001091498862,0.852409691101026
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39557,0.0173144006645043,0.0055829334050855,0.0063718511905367,0.0282569501384718,0.00193008679692134
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39557,0.0182327995569353,0.00565738956377506,0.00714431601193618,0.0293212831019344,0.00127190408325911
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39745,-0.115029622938594,0.00561531717839017,-0.126035644608239,-0.104023601268949,4.52419546656435e-92
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39745,-0.0349160492662034,0.00547249650100206,-0.0456421424081675,-0.0241899561242394,1.81659377063746e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39745,-0.00115653659973882,0.00571568985932381,-0.0123592887240135,0.0100462155245358,0.839650251859003
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39745,-0.101797101225449,0.00528026627218609,-0.112146423118934,-0.0914477793319646,6.96622828681151e-82
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39745,0.0737317418050552,0.00523178668626266,0.0634774398999803,0.08398604371013,7.80679312524522e-45
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39749,-0.0667245003824753,0.00574226027743787,-0.0779793305262536,-0.0554696702386971,4.36119054969027e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39749,-0.000764690155997172,0.00600422252695891,-0.0125329663088366,0.0110035859968423,0.898658090495606
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39749,0.013082903931359,0.00602234649933345,0.00127910479266543,0.0248867030700526,0.029840759261481
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39749,-0.0395922661085523,0.00588776189171107,-0.051132279416306,-0.0280522528007986,1.8220006870579e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39749,0.0161624101818825,0.00596739299989268,0.00446631990209288,0.0278585004616722,0.00676698371930563
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39749,-0.0572535586727187,0.00571012532418746,-0.0684454043081261,-0.0460617130373113,1.36768580979011e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39749,-0.0698744285855646,0.00551804960775061,-0.0806898058167557,-0.0590590513543734,1.4261524570889e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39749,-0.0736622969280571,0.00536194330289223,-0.0841717058017259,-0.0631528880543883,1.05465076130862e-42
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39749,-0.0542556455340488,0.00575345851677724,-0.0655324242269322,-0.0429788668411654,4.6509038005053e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39749,0.0673712263885395,0.00557749125305393,0.0564393435325538,0.0783031092445253,1.90811130052684e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39749,0.0194734650528279,0.00558400474488111,0.00852881575286089,0.0304181143527948,0.000489122862767836
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39749,-0.00472540691848079,0.00588977290695061,-0.016269361816104,0.00681854797914242,0.422387306639038
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39749,0.00996227160737967,0.00595413991864878,-0.00170784263317193,0.0216323858479313,0.0943140711530529
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39749,-0.0930835719732492,0.00532009627457325,-0.103510960671413,-0.0826561832750857,6.58452989702552e-68
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39749,0.000660200548342568,0.00583694685447022,-0.0107802152864191,0.0121006163831042,0.909947018459543
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39749,0.0705672499073813,0.00535629270395014,0.0600689162076391,0.0810655836071236,1.97673242889756e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39749,-0.0444858793337735,0.00562789557184114,-0.0555165546545821,-0.0334552040129649,2.86492158918827e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39749,-0.0337628390970499,0.00555868772833329,-0.0446578670445831,-0.0228678111495166,1.27695470539923e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39749,-0.0294869518795232,0.0055349710655247,-0.0403354951679516,-0.0186384085910948,1.00991925354158e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39749,0.0273399447781013,0.00569791745406258,0.0161720265681387,0.038507862988064,1.61524514512755e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39749,0.0351200646979411,0.00538333610455533,0.0245687259330127,0.0456714034628696,7.05973154304097e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39749,-0.0682190052631426,0.00562270221548077,-0.0792395016054849,-0.0571985089208003,9.982086614659e-34
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39749,-0.106308114888144,0.00525192665829916,-0.11660189113841,-0.0960143386378774,5.71055778484036e-90
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39749,0.0392502224790855,0.00596996549678134,0.0275490901053941,0.0509513548527769,5.02996051592391e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39749,0.0541087871131054,0.00551147539749426,0.0433062953340167,0.0649112788921942,1.09850319674192e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39749,0.080317521480635,0.00529411394350592,0.0699410581513634,0.0906939848099066,1.263612231385e-51
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39749,-0.108960454770673,0.00550228391379694,-0.119744931241715,-0.098175978299631,3.08347001510204e-86
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39749,-0.138915699176905,0.00541737236149339,-0.149533749005433,-0.128297649348378,3.91290841388288e-142
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39749,0.0693158129585564,0.00576712532502288,0.0580122473215115,0.0806193785956012,3.9250682663893e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39749,0.0768869895690922,0.00537226954117442,0.0663573412683903,0.087416637869794,3.57482252740584e-46
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39749,0.14848054312916,0.00533021415079084,0.13803332339361,0.15892776286471,8.92348478838307e-167
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39749,-0.148359273737722,0.00523968202402802,-0.158629050504817,-0.138089496970627,4.16622651956774e-172
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39749,-0.151249363110576,0.00533396344548627,-0.16170393146373,-0.140794794757423,1.36390856269848e-172
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39749,0.0107682989590788,0.00551544114531534,-4.1965685739281e-05,0.0215785636038969,0.0509093091317485
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39749,0.0253111478506625,0.00554505287377846,0.0144428442180567,0.0361794514832683,5.04112850820912e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39744,0.218744504034303,0.00581329368376088,0.207350448414131,0.230138559654474,6.72388646855388e-297
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39744,-0.149850738632657,0.00545059405608336,-0.16053390298258,-0.139167574282734,1.34584318524477e-162
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39744,-0.118739911237457,0.00523675087621022,-0.129003942954829,-0.108475879520085,4.7877323232626e-112
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39744,-0.125490945868523,0.00632195595901486,-0.137881979548192,-0.113099912188854,1.23404865522743e-86
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39744,-0.141160875863212,0.00583650987900774,-0.152600435226067,-0.129721316500357,6.12617403451668e-127
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39749,-0.0312806968198712,0.00597573152279974,-0.0429931306045587,-0.0195682630351837,1.67427207388362e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39749,0.0796793618034716,0.00606818685363847,0.0677857155703402,0.091573008036603,3.51435375200886e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39749,0.0595200070467918,0.00587069555061657,0.0480134437675834,0.0710265703260003,4.413301700962e-24
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39749,0.0785764006819138,0.00596522604443977,0.0668845576348119,0.0902682437290158,2.03547495600838e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39749,-0.0806725715004738,0.00573287239862838,-0.0919090014017854,-0.0694361415991622,1.04838948329847e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39749,0.000890369196044579,0.0060260542598359,-0.0109206971532338,0.0127014355453229,0.882539367797337
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39749,0.043978336793558,0.0058922829002495,0.032429462309069,0.055527211278047,8.84670886355396e-14
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39749,0.0414958341822975,0.00563602537788445,0.030449224441644,0.052542443922951,1.89188051486604e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39749,0.0127648280715424,0.00635063481745053,0.000317583829339312,0.0252120723137454,0.0444471914750443
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39749,-0.0679779962190373,0.00571198791473486,-0.0791734925319176,-0.0567824999061569,1.60870671911738e-32
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39749,0.139284017398566,0.00524061090040578,0.129012420033771,0.149555614763362,2.56726474701157e-152
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39749,-0.05230540350984,0.00532834993679037,-0.0627489693859492,-0.0418618376337309,1.10984679224486e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39749,-0.0528304593195179,0.00522877176877765,-0.0630788519863221,-0.0425820666527137,6.27680069226194e-24
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39749,-0.014683364163374,0.00581618509531498,-0.0260830869501913,-0.00328364137655661,0.0115936605448913
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39749,-0.0739266800965459,0.00583998538468223,-0.0853730514505231,-0.0624803087425687,1.50326381276319e-36
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51523,0.00391937684120548,0.00456482659686894,-0.00502768328865765,0.0128664369710686,0.390566655417856
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51523,0.00613477853145479,0.0044633151096555,-0.00261331908346998,0.0148828761463796,0.16930098693889
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49572,0.00419683841944781,0.00427993398307027,-0.00419183218736992,0.0125855090262655,0.326806734994498
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49572,0.00586093101598679,0.00461851857720271,-0.00319136539533052,0.0149132274273041,0.204450161938636
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49572,0.00430383289153484,0.00459524419552203,-0.00470284573168834,0.013310511514758,0.348981303386798
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49572,0.00274432465312047,0.00424146726542536,-0.00556895118711324,0.0110576004933542,0.517623172861475
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51523,-0.00589078227285333,0.0369591991971138,-0.0783308126991963,0.0665492481534897,0.873365860546633
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51523,0.00382243273294542,0.00399148574258084,-0.00400087932251302,0.0116457447884039,0.338249363755731
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51523,6.55777314109132e-05,0.00403252875363431,-0.00783817862571234,0.00796933408853417,0.987025342271401
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51523,0.00203326444646024,0.00408409960433032,-0.00597157077802718,0.0100380996709477,0.618594512513415
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51523,-0.00535303957323285,0.0255914957998833,-0.0555123713410041,0.0448062921945384,0.834315045898556
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51523,-0.000935865446269731,0.0248813224902685,-0.0497032575271959,0.0478315266346565,0.969996377553905
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51523,0.000263190031817939,0.00457876626915414,-0.00871119185572418,0.00923757191936005,0.954162809568319
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51523,0.000934364483157079,0.00457631078985149,-0.00803520466495184,0.00990393363126599,0.838218893080681
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51523,0.000518233000275015,0.00453150620847361,-0.00836351916833325,0.00939998516888328,0.908951510688736
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51474,0.000926085286922458,0.00439660537519525,-0.00769126124846023,0.00954343182230515,0.833172532448016
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51523,0.00450732190057294,0.0040016946762363,-0.00333599966485021,0.0123506434659961,0.260025787285752
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51523,0.00448056484490138,0.004000742240882,-0.00336088994722734,0.0123220196370301,0.262751868906396
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51523,0.00451286398325747,0.00400173628337732,-0.00333053913216208,0.012356267098677,0.259445230816316
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51523,0.0045116362128227,0.00400122574194031,-0.00333076624138031,0.0123540386670257,0.259514076881892
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51523,0.00450944963960325,0.00400133396910209,-0.00333316493983685,0.0123520642190433,0.259757935391258
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2405.Number of children fathered,36208,-0.0650118366849624,0.0278018644295141,-0.11950349096681,-0.0105201824031148,0.0193824608093612
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48367,-0.0046086230043847,0.00473848226305503,-0.0138960482399725,0.00467880223120315,0.330764348834923
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48367,-0.00221961651600299,0.00432571849423355,-0.0106980247647008,0.00625879173269478,0.607871386118986
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",48367,-0.000722382554504579,0.00423122104873016,-0.00901557581001569,0.00757081070100653,0.864440049411881
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48367,-0.00569738662433086,0.00447550252222713,-0.014469371567896,0.00307459831923431,0.203024415776469
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48367,8.8387199946621e-05,0.00437724733232951,-0.00849101757141921,0.00866779197131246,0.983890042034907
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",48367,0.00316853078631032,0.00425024874766846,-0.00516195675911986,0.0114990183317405,0.455980877297694
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51615,-0.00443924971943551,0.00450315904398741,-0.0132654414456508,0.00438694200677982,0.324235986271159
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51615,-0.00924727612711186,0.00425331601539198,-0.0175837755172801,-0.000910776736943578,0.0297035436515027
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,51615,-0.0092212879974843,0.00407634481997169,-0.0172109238446288,-0.00123165215033978,0.0236960701321906
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28653,-0.0111018678315882,0.0418083994037527,-0.0930463306629434,0.070842594999767,0.79060371422597
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,35567,-0.0413265767758875,0.0259485779819993,-0.0921857896206061,0.00953263606883111,0.111269412361664
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),38896,-0.0379370325630465,0.0228550393377525,-0.0827329096650415,0.0068588445389484,0.0969558403551684
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2734.Number of live births,39373,-0.0631182187244708,0.0219133942655183,-0.106068471484887,-0.0201679659640549,0.00397779629193903
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2744.Birth weight of first child,35517,-0.0430620111690398,0.0251961358713892,-0.0924464374769626,0.00632241513888311,0.0874642431623175
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2754.Age at first live birth,33493,-0.0081000590443614,0.00677711315744518,-0.021383200832954,0.00518308274423115,0.232035241157976
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2764.Age at last live birth,33473,-0.00723435462677048,0.00680036299604347,-0.0205630660990157,0.00609435684547471,0.287437469900202
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,37101,0.027181676375776,0.00670660520966393,0.0140367301648347,0.0403266225867173,5.0860219369519e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,35927,0.00307338151097698,0.00593432350271356,-0.00855789255434159,0.0147046555762955,0.604538080241057
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,29295,0.0121384880044949,0.00886881952767309,-0.0052443982697443,0.0295213742787342,0.171158991169471
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36455,0.0743690920936118,0.0302687123424492,0.0150424159024113,0.133695768284812,0.0140251189495114
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36450,0.0363674041636333,0.0335602992840001,-0.0294107824330069,0.102145590760273,0.278543598131347
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36471,0.0475395528714948,0.0343097853817007,-0.0197076264766386,0.114786732219628,0.165894349208541
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36443,0.0519473749538987,0.0334879975837551,-0.0136891003102613,0.117583850218059,0.120873241778312
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36484,0.0771530617344161,0.0314945228047487,0.0154237970371088,0.138882326431723,0.0143098468476439
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36507,0.0462642655041329,0.0348950501665813,-0.0221300328223665,0.114658563830632,0.184926030651463
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28741.Difficulty learning a new task,36413,0.0801618877718095,0.0397395234393444,0.00227242183069455,0.158051353712925,0.0436976776107179
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35977,0.0575243332639522,0.0379644951651345,-0.0168860772597115,0.131934743787616,0.12974431836284
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36421,0.0338929645653037,0.0326574352912744,-0.0301156086055941,0.0979015377362015,0.299367785278433
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36506,0.0606277111356142,0.0444637273113857,-0.0265211943947018,0.14777661666593,0.172739211839608
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29141,-0.0373439236472686,0.0409530198671106,-0.117611842586805,0.0429239952922681,0.361877585076575
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,29298,0.00634432843712394,0.0106861147319896,-0.0146004564375756,0.0272891133118235,0.552738595880292
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35124,-0.0192730725593915,0.0126493373417741,-0.0440657737492687,0.00551962863048574,0.127626022894292
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35124,0.0231530462250354,0.0135864438065773,-0.00347638363585615,0.049782476085927,0.0883846617668118
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35124,-0.0572684316280568,0.0456282822099554,-0.146699864759569,0.0321630015034558,0.209465518746571
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35124,-0.0509413624387751,0.0447426248754336,-0.138636907194625,0.0367541823170749,0.254918400537976
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35124,0.0170214659586351,0.0482520247265443,-0.0775525025053918,0.111595434422662,0.724273704483453
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35124,-0.0165266073174026,0.0412556525039601,-0.0973876862251643,0.0643344715903592,0.688729508988873
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35124,-0.00778994812555988,0.0187802440683907,-0.0445992264996056,0.0290193302484859,0.678300004934342
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35124,0.0240852231963124,0.0345382122785517,-0.043609672869649,0.0917801192622738,0.485598161191577
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35052,0.040347465984476,0.0347800930890645,-0.0278215164700903,0.108516448439042,0.246043613191662
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29003.Recent feelings of depression,35048,0.0544953890760567,0.0337484879626462,-0.0116516473307298,0.120642425482843,0.106392932358492
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35059,0.0461802084295522,0.0277733690477673,-0.00825559490407166,0.100616011763176,0.0963901961309382
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35065,0.0504822610200335,0.0282596421857029,-0.00490663766394425,0.105871159704011,0.074065922489614
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35067,0.0365553236325651,0.0370446084746615,-0.0360521089777714,0.109162756242902,0.32376592014359
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35029,0.0583812748303955,0.0362025155684468,-0.0125756556837604,0.129338205344551,0.106853101544683
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35063,0.0431325943417827,0.0360781687274613,-0.0275806163640415,0.113845805047607,0.231904668766226
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35055,0.0466522648771806,0.0640452845541263,-0.078876492848907,0.172181022603268,0.466367953320164
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,34992,0.0299601214299274,0.0703009380308748,-0.107829717110587,0.167749959970442,0.669992521378183
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,32647,0.00538634256926782,0.0245596335477569,-0.0427505391843358,0.0535232243228714,0.826408296085293
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32647,-0.0323776388397128,0.0438511467923098,-0.11832588655264,0.0535706088732144,0.460319505731326
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32647,0.0553135814048727,0.0241478548943475,0.00798378581195158,0.102643376997794,0.0220089189648286
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32647,0.0229907993161904,0.0685679171489641,-0.111402318295779,0.15738391692816,0.737407054390189
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32647,0.0524771134034949,0.0415550242046067,-0.0289707340375341,0.133924960844524,0.206682214737384
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32647,0.0396974993921241,0.0446194016369385,-0.0477565278162755,0.127151526600524,0.373655951662251
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32647,0.0231731655836515,0.0503332437981649,-0.0754799922607518,0.121826323428055,0.645244232425649
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32647,-0.0284106086506573,0.0620394709970844,-0.150007971804943,0.0931867545036281,0.64700393853484
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32647,0.0207514509521347,0.0491890212951299,-0.0756590307863199,0.117161932690589,0.673129063460189
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32647,0.0170230492791531,0.0249526914649592,-0.0318842259921669,0.065930324550473,0.49512228900794
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32647,-0.0234814274039908,0.036344242912632,-0.0947161435127495,0.047753288704768,0.51824194374699
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32647,0.0530314645051265,0.057576962653709,-0.0598193822961433,0.165882311306396,0.357047767877598
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32647,0.0550331991299095,0.071635073829602,-0.0853715455761104,0.195437943835929,0.442363019749948
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32647,0.0446619028876188,0.0439746676744088,-0.0415284457542224,0.13085225152946,0.309834539216488
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32647,0.193846353934391,0.0746774596799594,0.0474785329616701,0.340214174907111,0.00945331255348778
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32647,0.0230952527786291,0.0720620430080626,-0.118146351517173,0.164336857074432,0.748603598656177
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32647,0.0260404343086847,0.0381413343727662,-0.048716581061937,0.100797449679307,0.494792135622351
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32647,0.0653674151075788,0.0372546187464816,-0.00765163763552516,0.138386467850683,0.0793604842409414
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32647,0.097001093838126,0.0535625420775497,-0.00798148863387135,0.201983676310123,0.0701769224885042
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,34893,0.0172532749419474,0.0322517672601985,-0.0459601888880416,0.0804667387719364,0.592691097577334
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,34899,0.0509984738332572,0.0338368945559198,-0.0153218394963456,0.11731878716286,0.131791759062685
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29060.Recent worrying too much about different things,34891,0.0179102310483471,0.0309797596079885,-0.0428100977833103,0.0786305598800046,0.563190279667089
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29061.Recent trouble relaxing,34897,0.041990915053791,0.0324762328345876,-0.0216625013020008,0.105644331409583,0.196047222672575
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29062.Recent restlessness,34900,0.0454442962428391,0.0454246949390378,-0.0435881058376749,0.134476698323353,0.31712365691563
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,34883,0.0772652281342347,0.0328913667742438,0.012798149256717,0.141732307011752,0.0188362280612477
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29064.Recent feelings of foreboding,34875,-0.00222133255936614,0.0375770453978929,-0.0758723415392363,0.071429676420504,0.952862314643003
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32647,-0.0170107217437375,0.0249223838631265,-0.0658585941154654,0.0318371506279905,0.49491053326264
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32647,0.0287617864628042,0.041296345373403,-0.0521790504690658,0.109702623394674,0.48615112978551
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32647,-0.00199275535804522,0.0539975812395616,-0.107828014587586,0.103842503871495,0.970561966090182
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32647,0.0152035993770309,0.0598304873657364,-0.102064155859812,0.132471354613874,0.799415565310626
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32647,-0.0375309963532085,0.0373803059499144,-0.110796396015041,0.0357344033086238,0.315391185023241
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32647,0.00208309373988744,0.0402437616170667,-0.0767946790295633,0.0809608665093382,0.95871958734013
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32647,-0.0237332219805402,0.0403952035460173,-0.102907820930734,0.0554413769696538,0.556865763103401
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32647,-0.011819745570598,0.0364417732938495,-0.083245621226543,0.059606130085347,0.745683772706968
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32647,-0.0705520246666394,0.0486561570424947,-0.165918092469929,0.0248140431366502,0.147090788811017
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29076.Felt loved as a child,34847,-0.0796457133151401,0.0291302106288144,-0.136740926147616,-0.0225505004826639,0.00626460256833993
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29077.Physically abused by family as a child,34851,0.0618479349439542,0.0371503109736358,-0.0109666745643721,0.13466254445228,0.09598065210004
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29078.Felt hated by family member as a child,34836,0.163413179303331,0.0381551771201437,0.088629032147849,0.238197326458812,1.86079136940807e-05
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29079.Sexually molested as a child,34755,0.130030696992547,0.0519506373141126,0.0282074478568867,0.231853946128208,0.0123302517591939
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,34833,-0.0484365229802115,0.0434996329217373,-0.133695803506817,0.0368227575463936,0.265521286160287
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34838,-0.00799322399887128,0.0510510569053335,-0.108053295533325,0.0920668475355825,0.875584156339223
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34776,0.0565420938307985,0.0407004664503971,-0.0232308204119799,0.136315008073577,0.164792768838219
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34845,-0.016432077701946,0.0449097025000852,-0.104455094602113,0.0715909391982211,0.714453097357481
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34807,-0.00420454803749485,0.06306744445181,-0.127816739163043,0.119407643088053,0.946847635837393
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34806,0.0219523641660752,0.0615533039730174,-0.098692111621039,0.142596839953189,0.721368278258856
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,34844,-0.0233290768971651,0.0496861058264717,-0.12071384431705,0.0740556905227194,0.638700748180879
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,34852,0.0475365832853826,0.0353683102200064,-0.0217853047458299,0.116858471316595,0.17896173518079
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,34852,-0.0346784605463573,0.0312906563994355,-0.0960081470892509,0.0266512259965363,0.267769964597136
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,34864,0.00945180529165375,0.0497880418841159,-0.0881327568012134,0.107036367384521,0.84943732883683
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34849,0.00898338938509117,0.0388039852704858,-0.067072421745061,0.0850392005152433,0.816925355451526
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,34858,-0.28750911370635,0.026638646268305,-0.339720860392228,-0.235297367020472,5.07653881068592e-27
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33754,-0.236318306652293,0.0293123237879116,-0.2937704612766,-0.178866152027986,8.36923074797754e-16
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33769,-0.27071608470306,0.0297631532071264,-0.329051864989028,-0.212380304417092,1.12076546318569e-19
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29104.Ever used cannabis,34844,-0.0201886708231276,0.034858617944078,-0.0885115619935206,0.0481342203472653,0.562493994941798
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29108.Ever thought that life not worth living,34798,0.131549614881953,0.0319990637186309,0.0688314499934361,0.194267779770469,3.9674860393632e-05
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29109.Ever contemplated self-harm,34816,0.0699797357006144,0.0413641153836613,-0.0110939304513618,0.151053401852591,0.0907128982589571
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29111.Ever self-harmed,34833,-0.0102786569804826,0.0646393446055372,-0.136971772407335,0.11641445844637,0.873659597506764
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34839,0.0984865752829317,0.0449199502306657,0.010443472830827,0.186529677735036,0.0283650054488083
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33355,0.081465205226722,0.0508124385262409,-0.0181271742847102,0.181057584738154,0.108912023345199
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33355,-0.00371309341959223,0.0399235047810449,-0.0819631627904402,0.0745369759512558,0.925901394885719
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33355,0.0433135751795849,0.0417213054723137,-0.0384601835461499,0.12508733390532,0.299219947408657
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33355,-0.00200390904346768,0.0552227958305349,-0.110240588871316,0.106232770784381,0.971053708802012
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34831,0.0266532475296496,0.0294367356215009,-0.0310427542884923,0.0843492493477914,0.365251325292414
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X29153.Pain or discomfort today,34847,0.0122714938886921,0.0282346496999781,-0.043068419523265,0.0676114073006493,0.663842945380896
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29154.Anxiety or depression today,34847,0.0418774099316274,0.0344509849719468,-0.0256465206133883,0.109401340476643,0.224176816946307
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,34609,-0.0868357958917994,0.0275114076998539,-0.140758154983513,-0.0329134368000856,0.00160195097091425
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34813,0.00597388737975533,0.0131707432780754,-0.0198407694452724,0.031788544204783,0.650145513144766
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34813,0.00422768951197148,0.0130879743011949,-0.0214247401183704,0.0298801191423134,0.746685564269609
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34813,-0.0796135251591506,0.0162955107047514,-0.111552726140463,-0.047674324177838,1.04568237737584e-06
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34813,0.0527437033823679,0.0194260766350368,0.0146685931776957,0.09081881358704,0.00663599804915208
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34813,0.0297791785704815,0.0301101252795343,-0.0292366669774057,0.0887950241183687,0.322680688140512
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34813,0.00349405445241477,0.0141520406259802,-0.0242439451745065,0.0312320540793361,0.804994857862781
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34812,-0.0134890982555913,0.0154972840280926,-0.0438637749506529,0.0168855784394702,0.384091679786144
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34812,0.0170950752403475,0.0218814794081644,-0.0257926243996546,0.0599827748803497,0.434667804763196
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34812,-0.119162772793378,0.0353016869094652,-0.18835407913593,-0.0499714664508262,0.000739230187705405
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34812,0.0524967017176901,0.03485066052209,-0.0158105929056064,0.120803996340986,0.132010538847298
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34812,0.0226712272432764,0.0465598997179331,-0.0685861762038725,0.113928630690425,0.626320494449077
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34812,-0.0116533561551354,0.0232326022775439,-0.0571892566191215,0.0338825443088506,0.615962549471849
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34626,-0.0731852543618268,0.0335431241761122,-0.138929777747007,-0.00744073097664696,0.0291439417675494
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,34765,0.105391753835093,0.0308998494607788,0.0448280488919667,0.16595545877822,0.000650187279896624
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29173.Frequency of feeling left out,34722,0.0843681319258657,0.0315874989447227,0.0224566339942093,0.146279629857522,0.00757531899785619
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,34752,0.124073396619926,0.0326948943196364,0.0599914037534383,0.188155389486413,0.000148511504341136
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,34831,-0.0801577822350728,0.0275503752807626,-0.134156517785367,-0.0261590466847781,0.00362736171501388
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29176.Ability to make it through stressful events,34831,0.0297198188450575,0.0268199224655377,-0.0228472291873964,0.0822868668775114,0.267832259181047
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29177.Quick recovery from stressful events,34831,-0.0489292896156898,0.0271432849606744,-0.102130128138612,0.00427154890723212,0.0714738410501232
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,34831,0.0705219924043943,0.0269386354821846,0.0177222668593125,0.123321717949476,0.00886006312666422
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,34831,-0.0862269547444076,0.0271234672369157,-0.139388950528762,-0.0330649589600529,0.00148167370565815
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,34831,0.080176320740232,0.0270490409636813,0.0271602004514167,0.133192441029047,0.00304212798832426
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29181.General happiness,34765,0.0779605438431642,0.0280283510541606,0.0230249757770095,0.132896111909319,0.00542031445226371
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29182.Belief that own life is meaningful,34661,-0.0863643595263418,0.0281251112141232,-0.141489577506023,-0.0312391415466603,0.00214073457167412
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28840,-0.0631915757155568,0.0399995906484793,-0.141590773386576,0.0152076219554625,0.114214923337473
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2946.Father's age,34021,0.00386463559956442,0.00983130328470475,-0.0154047188384569,0.0231339900375857,0.69425760611119
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,29021,-0.0112661406905937,0.0160253258024844,-0.0426757792634631,0.0201434978822758,0.482074367802024
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51040,0.0202448090987537,0.00420050850110587,0.0120118124365862,0.0284778057609212,1.44615763103127e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51040,-0.0470118840069449,0.00494974683038569,-0.0567133877945009,-0.037310380219389,2.31295384804831e-21
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51040,-0.0710847426552785,0.00526843563568506,-0.0814108765012213,-0.0607586088093358,2.3507005471807e-41
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51040,-0.0611573184131792,0.00516132325058754,-0.0712735119843308,-0.0510411248420276,2.61092114174166e-32
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51040,-0.00597431379788215,0.004199330347902,-0.0142050012797701,0.00225637368400577,0.154839692391352
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51039,-0.0130299394282174,0.00421027722782068,-0.0212820827947459,-0.00477779606168886,0.00197149827213874
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51039,-0.0164200975334763,0.00410491488851742,-0.0244657307149704,-0.00837446435198214,6.34814470641023e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51040,0.0437856639530453,0.00399781519268913,0.0359499461753746,0.051621381730716,7.40019410951098e-28
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30080.Platelet count,51040,-0.021356192024623,0.00423807750491344,-0.0296628239342533,-0.0130495601149927,4.70667486027648e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30090.Platelet crit,51040,-0.00580676599059879,0.00434118166974042,-0.01431548206329,0.00270195008209244,0.181037952254833
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51040,0.0323083607163063,0.00407728729236758,0.0243168776232658,0.0402998438093467,2.38772928561958e-15
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51040,-0.00231987133892733,0.0040447472175732,-0.0102475758853708,0.00560783320751613,0.566276000579134
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51007,0.0154325663073542,0.00427341719552979,0.00705666860411585,0.0238084640105926,0.000305221923169028
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30130.Monocyte count,51007,0.0525025193215147,0.00425315120352557,0.0441663429626046,0.0608386956804248,6.48175873852681e-35
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51007,0.00725793250803503,0.0041638865366341,-0.000903285103767792,0.0154191501198379,0.0813332635106497
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51007,0.0300247618301855,0.00408358588703217,0.0220209334916025,0.0380285901687686,1.99958278682299e-13
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30160.Basophill count,51007,0.0609758307328518,0.0186639420360496,0.0243945043421946,0.097557157123509,0.00108813504918462
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51007,0.184094625100151,0.0813177074058095,0.0247119185847647,0.343477331615538,0.0235885257691849
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51007,-0.000733992941988001,0.00420064584614805,-0.00896725880043818,0.00749927291646218,0.861290460484945
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51007,0.041742082569472,0.00419980892628013,0.0335104570739629,0.049973708064981,3.0847859469734e-23
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51007,-0.0175940124567253,0.00413692054068542,-0.0257023767164687,-0.00948564819698189,2.11701849525891e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51007,0.0239179013110753,0.00402979590651518,0.0160195013343055,0.031816301287845,2.96932886329688e-09
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51007,0.0102047864485835,0.00400658938170666,0.0023518712604385,0.0180577016367286,0.0108707862561212
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51006,0.183441852631223,0.0814880579424226,0.0237252590640745,0.343158446198371,0.0243839953028274
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,50557,-0.0842827695961692,0.00427215329405913,-0.0926561900525251,-0.0759093491398133,5.04843335651889e-86
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,50557,-0.0933562236380649,0.00437564746829518,-0.101932492675923,-0.0847799546002064,3.65966478237435e-100
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,50557,0.00374220913756749,0.00416815261858757,-0.00442736999486416,0.0119117882699991,0.369294944468414
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,50557,0.0123056274615929,0.00418663069220006,0.00409983130488079,0.020511423618305,0.00329270722114588
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50557,-0.0399428098505899,0.00433394253503453,-0.0484373372192575,-0.0314482824819222,3.29571289995358e-20
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50557,-0.0844027664039079,0.00437176553101732,-0.0929714268447018,-0.075834105963114,1.73629874470372e-82
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50557,-0.0919139544417703,0.00444304874504253,-0.100622329982054,-0.083205578901487,2.48795433047242e-94
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,32004,0.00189280303910452,0.00780615053546508,-0.013407252010407,0.0171928580886161,0.808417568147813
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51163,0.00434939883177383,0.00427901647191762,-0.0040374734531847,0.0127362711167324,0.309424982797059
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51100,-0.0281573510155859,0.00395995205702287,-0.0359188570473508,-0.0203958449838211,1.1844914006726e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51104,0.0191703765843107,0.00412276597280029,0.0110897552776221,0.0272509978909993,3.33681647415435e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30600.Albumin,48376,-0.0586043848227485,0.00442296025999753,-0.0672733869323436,-0.0499353827131533,6.18815809754642e-40
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,50648,0.0604531289180767,0.00418745724447476,0.0522457127189062,0.0686605451172473,4.56756470830678e-47
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,50640,-0.0225145036291053,0.00443637348556075,-0.0312097956608044,-0.0138192115974063,3.90128608087478e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,48240,-0.042240664780131,0.00481970703302941,-0.0516872905648686,-0.0327940389953933,2.00204529849879e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50490,-0.21609734851584,0.00405742316521504,-0.224049897919661,-0.208144799112018,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,50567,0.0220914587782353,0.00416251135667552,0.0139329365191513,0.0302499810373193,1.12183172504987e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,46495,-0.0445164917513216,0.00453533729112959,-0.0534057528419356,-0.0356272306607076,1.07203750081977e-22
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30670.Urea,50640,0.0827513176752125,0.00434772776660824,0.0742297712526604,0.0912728640977647,3.0679032404352e-80
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30680.Calcium,48372,-0.043020356395594,0.00431594896572622,-0.0514796163684174,-0.0345610964227707,2.33674913593219e-23
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30690.Cholesterol,50653,-0.184641733936102,0.00424061418261583,-0.192953337734029,-0.176330130138175,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30700.Creatinine,50642,0.0657727495747424,0.00529584356744006,0.0553928961825599,0.076152602966925,2.5567798734308e-35
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30710.C-reactive protein,50571,-0.0214404482633813,0.00455644456323434,-0.0303710796073206,-0.012509816919442,2.54485318990419e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30720.Cystatin C,50647,0.0442027321773954,0.00488449195302052,0.0346291279494751,0.0537763364053156,1.52964789873887e-19
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50639,-0.0775806650240006,0.0044994403270279,-0.0863995680649752,-0.0687617619830259,2.91652782730019e-66
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30740.Glucose,48339,-0.0243046511389671,0.00440008416450044,-0.0329288161013879,-0.0156804861765462,3.35349024122215e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50410,0.0342257412377897,0.00441356202372684,0.0255751596712851,0.0428763228042943,9.17357387084641e-15
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,48356,0.00185595503985982,0.00511251926052755,-0.00816458271077418,0.0118764927904938,0.716591864030119
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30770.IGF-1,50528,0.0109520568284235,0.00432050364187938,0.00248386969033989,0.019420243966507,0.0112535190777529
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30780.LDL direct,50596,-0.195876919404897,0.00417509305073168,-0.204060101784331,-0.187693737025463,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,45316,0.0122075690758965,0.00457616152938813,0.00323829247829577,0.0211768456734972,0.0076442544955429
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30810.Phosphate,48311,0.0503394566468561,0.00430427935839858,0.0419030691043949,0.0587758441893173,1.63616159774036e-31
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30830.SHBG,48131,0.0713072397924848,0.00498600449844164,0.0615346709755392,0.0810798086094305,3.30175785297991e-46
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30840.Total bilirubin,50555,-0.129917838991338,0.00418658783587006,-0.138123551149643,-0.121712126833033,9.82386090259715e-208
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30850.Testosterone,48505,-0.0443640204352105,0.00714106521398531,-0.0583605082546217,-0.0303675326157993,5.29750995671235e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30860.Total protein,48356,-0.0678794012632751,0.00437183714026146,-0.0764482020581875,-0.0593106004683626,4.1575815333066e-54
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30870.Triglycerides,50630,-0.0900003827263906,0.0043379047288602,-0.0985026759949566,-0.0814980894578246,7.22208722042913e-95
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30880.Urate,50618,-0.0952523765538672,0.00523219090726831,-0.105507470732113,-0.0849972823756213,1.31000526369613e-73
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30890.Vitamin D,49554,0.0307057698373991,0.00452251808101311,0.0218416343986134,0.0395699052761848,1.14949293703678e-11
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3137.Number of measurements made,49674,0.0138786300306733,0.0212067805302346,-0.0276866598085865,0.0554439198699331,0.512832240371365
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3143.Ankle spacing width,39779,-0.0133788217810046,0.00739104806438457,-0.0278652759871984,0.00110763242518912,0.0702931366070909
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39778,-0.0122429017984765,0.00567060455531189,-0.0233572867268878,-0.00112851687006518,0.0308641497125895
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3146.Speed of sound through heel,39779,-0.015118893562281,0.00551382823988745,-0.0259259969124604,-0.0043117902121016,0.00611353476800981
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39779,-0.0145939980738271,0.00556563680392153,-0.0255026462095133,-0.00368534993814086,0.00874572058535569
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),39769,-0.0152770496921056,0.00557229228243912,-0.0261987425656862,-0.00435535681852488,0.00612072741052682
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3526.Mother's age at death,35233,-0.00755748838109751,0.00749071773091158,-0.0222392951336842,0.00712431837148919,0.313037447529237
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),30340,-0.00249864764280825,0.0103026471227737,-0.0226918360034446,0.0176945407178281,0.808381201165492
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30296,0.00552085845953389,0.00959686571529476,-0.0132889983424438,0.0243307152615116,0.565123919743489
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4100.Ankle spacing width (left),32720,-0.0126918368686639,0.00997095048252405,-0.032234899814411,0.00685122607708325,0.20309354858873
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32719,-0.0086902633919762,0.00768815789554804,-0.0237590528672504,0.00637852608329796,0.258361889023607
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),32720,-0.0230079152835368,0.00749961576980995,-0.0377071621923643,-0.00830866837470932,0.00216234483105771
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32720,-0.0188350649377947,0.00756670889935471,-0.0336658143805299,-0.00400431549505946,0.0128212369274307
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32712,-0.0191185447078214,0.00758829238323344,-0.033991597778959,-0.00424549163668389,0.0117703182883963
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32720,-0.0188386965770096,0.00756679943644778,-0.0336696234724473,-0.004007769681572,0.012805022599921
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4119.Ankle spacing width (right),32715,-0.0263406481873692,0.00977909843727422,-0.0455076811244266,-0.00717361525031168,0.00708253118260046
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32715,-0.0078194865530722,0.00773940322536849,-0.0229887168747944,0.00734974376865005,0.312356446726151
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),32715,-0.0226151955901431,0.00753544539597491,-0.0373846685662539,-0.00784572261403226,0.0026968880890772
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32715,-0.0181462853476018,0.00760804555278758,-0.0330580546310654,-0.00323451606413811,0.0170933385791264
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32706,-0.0179516330361685,0.00763511151642408,-0.0329164516083597,-0.00298681446397732,0.0187350648524518
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32715,-0.0181468800545009,0.00760808124499399,-0.0330587192946891,-0.00323504081431264,0.0170902286368559
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4194.Pulse rate,33014,0.0341069746835169,0.00723238732771667,0.0199314955211922,0.0482824538458415,2.44243007353298e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4195.Pulse wave reflection index,33014,-0.0251636014021839,0.00709623019845073,-0.0390722125911473,-0.0112549902132205,0.000393002991234642
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,33009,0.0151238103452752,0.00762156660768992,0.000185539794202929,0.0300620808963474,0.0472473263505287
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,33014,-0.019710138869432,0.00729955167273998,-0.0340172601480023,-0.0054030175908616,0.00694283758846859
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4199.Position of pulse wave notch,33014,0.0335962396944074,0.00714859204495778,0.0195849992862901,0.0476074801025246,2.64345589207461e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33014,-0.000537195685787715,0.00748179587249653,-0.0152015155958809,0.0141271242243055,0.942762349712141
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),32878,0.197121471947522,0.100732820780479,-0.000314856782217127,0.394557800677262,0.0503931032892223
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4270.Volume level set by participant (left),32796,-0.00363706691802121,0.0290389060190049,-0.0605533227152708,0.0532791888792283,0.900329981297029
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),32885,0.0924238696258194,0.097909483017417,-0.0994787170883178,0.284326456339957,0.345208954117323
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4277.Volume level set by participant (right),32788,-0.0407871765808059,0.0288921961937671,-0.0974158811205895,0.0158415279589776,0.158072530095216
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4288.Time to answer,33045,0.00878259653131994,0.00817848324501582,-0.00724723062891107,0.0248124236915509,0.282910875157366
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4290.Duration screen displayed,33045,0.0146341300796435,0.00730541741095458,0.000315511954172523,0.0289527482051145,0.0451863577695261
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X46.Hand grip strength (left),51857,-0.0446627612927569,0.00570506092334355,-0.0558446807025103,-0.0334808418830036,5.10602431961917e-15
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X47.Hand grip strength (right),51836,-0.0462545944893839,0.005650025263676,-0.0573286440061889,-0.035180544972579,2.79989162638979e-16
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X48.Waist circumference,51914,-0.111439362357147,0.00892291321006136,-0.128928272248867,-0.0939504524654264,1.06522763892439e-35
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X4803.Tinnitus,32833,0.0306719878109207,0.0357200902584594,-0.0393393890956596,0.100683364717501,0.390542184172452
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4825.Noisy workplace,32973,-0.0477403830935894,0.0395346345515865,-0.125228266814699,0.0297475006275201,0.227248485115498
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,32911,-0.0328054720957722,0.0424223839281569,-0.11595334459496,0.0503424004034153,0.43936167173912
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X49.Hip circumference,51910,0.0020734670104086,0.00704930645097743,-0.0117431736335072,0.0158901076543244,0.76865483607817
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X50.Standing height,51886,-0.0195527463469558,0.00559256650299047,-0.0305141766928171,-0.0085913160010945,0.000472659754516958
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X5057.Number of older siblings,32180,0.0251075869310581,0.0306547964802284,-0.0349758141701896,0.0851909880323057,0.412785520536949
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X51.Seated height,51748,-0.0103909642176648,0.00519497757370808,-0.0205731202621326,-0.000208808173196963,0.045488972417495
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5181.Ever had eye surgery,30065,-0.076733154614325,0.0752501387754966,-0.224223426614298,0.0707571173856483,0.307906822074613
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30050,-0.0154577896156193,0.00907831693639767,-0.0332512908109587,0.00233571157972014,0.0886715555341454
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30048,-0.0141053644096125,0.0089892693207894,-0.0317243322783597,0.0035136034591347,0.116667944859353
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),29994,-0.0058331298171716,0.0088860095425864,-0.0232497085206409,0.0115834488862977,0.511565850411819
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),29992,-0.00693469276710419,0.00889948464344141,-0.0243776826682493,0.010508297134041,0.435877796153423
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",30026,0.06437551782571,0.0354106874784536,-0.00502942963205905,0.133780465283479,0.0691174438492106
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),30026,0.00518449981227717,0.270687001397242,-0.525362022926317,0.535731022550871,0.984719577844381
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5201.logMAR, final (right)",29972,0.00696620861054417,0.00862886262230873,-0.00994636212918094,0.0238787793502693,0.419516547591872
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5202.Number of rounds to result (right),30026,0.0531476641227585,0.0336232620371576,-0.0127539294700704,0.119049257715587,0.114002291785205
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",30022,0.0813971094290868,0.035304413602197,0.0122004587687807,0.150593760089393,0.0211672316457113
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),30022,0.0808727623917652,0.244596575158535,-0.398536524918964,0.560282049702494,0.740929678492823
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5208.logMAR, final (left)",29974,0.00835198763887469,0.00865246566545594,-0.00860684506541896,0.0253108203431683,0.334446492345282
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5209.Number of rounds to result (left),30018,0.0365937551424947,0.0336407406036088,-0.0293420964405785,0.102529606725568,0.276734491169645
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29780,-0.0383836154363066,0.00896987540309923,-0.0559645712263811,-0.0208026596462321,1.90550222584462e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29780,-0.0402887215553971,0.00880994617897884,-0.0575562160661957,-0.0230212270445986,4.90358145525049e-06
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),29780,0.00886256225738781,0.00904623591217792,-0.00886806013048093,0.0265931846452565,0.327276173771925
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),29780,-0.0128520861618278,0.00887805585018592,-0.0302530756281922,0.00454890330453657,0.147775205608489
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29757,-0.040767268825752,0.00902449706615221,-0.0584552830754103,-0.0230792545760937,6.38240848775806e-06
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29757,-0.0356749160034051,0.00883977018069498,-0.0530008655575672,-0.0183489664492429,5.51219269238068e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),29757,0.00942068788415406,0.00904752908132623,-0.00831246911524536,0.0271538448835535,0.297804877229679
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),29757,-0.0130929513340562,0.00886833408286097,-0.0304748861364637,0.00428898346835127,0.139897716250176
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29873,-0.0539863381695788,0.144853619785602,-0.337899432949359,0.229926756610202,0.709387988098326
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51815,0.0349656773562275,0.0245143215174162,-0.0130823928179083,0.0830137475303633,0.153782332475576
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51815,0.0364989070299324,0.0273828560326516,-0.0171714907940647,0.0901693048539295,0.182571910967244
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51815,0.119887607808014,0.0637651086773957,-0.00509200519968137,0.24486722081571,0.0600987989236045
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51815,0.0201869864149433,0.0112537785024543,-0.00187041944986705,0.0422443922797537,0.0728564885138299
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51815,-0.0303731887286954,0.0100906640586763,-0.0501508902837009,-0.0105954871736899,0.00261455943916698
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37748,-0.00750516660069318,0.0114424411834343,-0.0299323513202243,0.014922018118838,0.511895429635715
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37748,-0.0173665924604374,0.0403954661026476,-0.0965417060216266,0.0618085211007518,0.667264582305008
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37748,0.0116644670607192,0.0195311667259045,-0.0266166197220536,0.0499455538434921,0.550368068157979
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37748,-0.0266912086304293,0.0123556575043699,-0.0509082973389943,-0.0024741199218644,0.030771001619171
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51898,-0.00810564967881911,0.0228512404749695,-0.0528940810097593,0.036682781652121,0.722806701084661
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51898,-0.00810564967881911,0.0228512404749695,-0.0528940810097593,0.036682781652121,0.722806701084661
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51898,-0.0306365553481259,0.0166684179442817,-0.063306654518918,0.00203354382266613,0.0660729504678654
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51898,-0.0135277793791886,0.0258682386895033,-0.064229527210615,0.0371739684522378,0.601013612424266
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51898,-0.0861647146249007,0.0629736892136741,-0.209593145483702,0.0372637162339005,0.171240008087392
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51898,-0.0556029834786643,0.0446933192183683,-0.143201889146666,0.0319959221893377,0.213472955288609
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51898,-0.0140857567936635,0.0680382873032632,-0.147440799908059,0.119269286320732,0.835990341282218
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51814,0.0199250208652303,0.012776164264437,-0.00511626109306623,0.0449663028235269,0.118878433986301
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51814,0.016523408232151,0.0220860825780645,-0.0267653136208553,0.0598121300851574,0.454384020453921
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51814,-0.011704044348256,0.0107408966572565,-0.0327562017964787,0.00934811309996679,0.275867457652746
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51814,0.0428592607120757,0.0203270227026916,0.00301829621480021,0.0827002252093512,0.034997769878777
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51814,0.0261488193493179,0.0175705665892674,-0.00828949116564623,0.0605871298642821,0.136704903800776
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51814,0.0190999057298062,0.0142907683603439,-0.00891000025646793,0.0471098117160803,0.181390062925143
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30049,0.163215933417926,0.037981080842872,0.0887730149658972,0.237658851869956,1.75544296365332e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30049,0.126198298331966,0.0328350755760444,0.0618415502029194,0.190555046461013,0.000122557301017971
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30049,0.150381271765911,0.0412620618236345,0.0695076305915879,0.231254912940235,0.000270065309512396
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30049,-0.175590099219202,0.0338551543529393,-0.241946201750963,-0.109233996687441,2.21080319909983e-07
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51767,0.0463278804550188,0.0361185033246165,-0.0244643860612296,0.117120146971267,0.199620698722907
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51767,-0.0317953664960571,0.0511451226330148,-0.132039806856766,0.0684490738646519,0.534164241770253
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51767,0.270800295350934,0.107553508924261,0.0599954178593824,0.481605172842486,0.0118139402776938
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51767,0.0642790621379903,0.0910764002851351,-0.114230682420875,0.242788806696855,0.480336586933591
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51767,0.0407481061402315,0.0329246838232398,-0.0237842741533184,0.105280486433782,0.215868996833518
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51767,0.11949365956505,0.0418415940493151,0.0374841352283922,0.201503183901707,0.00429523473439335
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51767,0.0256489481439389,0.0172543941394719,-0.00816966436942607,0.0594675606573039,0.13715375239204
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33520,0.0531990635407461,0.0331051351423136,-0.0116870013381886,0.118085128419681,0.108092939650918
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33520,0.0131410032355408,0.0373345139409158,-0.0600346440886542,0.0863166505597359,0.724860918936466
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33520,0.0615935266264127,0.0478113123092429,-0.0321166454997035,0.155303698752529,0.197685414761283
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33520,0.00348966530138509,0.0142197032884525,-0.0243809531439819,0.031360283746752,0.806143769045525
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35667,0.0667337334953773,0.0155231863804458,0.0363082881897035,0.097159178801051,1.72969485480985e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35667,-0.0432417030751336,0.0125505230449513,-0.0678407282432382,-0.018642677907029,0.000572175961193811
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35667,0.00776611802319378,0.0124308332257423,-0.0165983150992611,0.0321305511456486,0.532149601931014
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35668,-0.0292096253740464,0.030327425918838,-0.0886513801749689,0.0302321294268762,0.335495862442546
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35668,-0.0344301713275742,0.0197753781538323,-0.0731899125090855,0.00432956985393706,0.0816986510201395
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35668,0.0343793898717658,0.0248080903883083,-0.0142444672893185,0.0830032470328501,0.165829989776688
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51814,0.0536245738782751,0.0297398428915114,-0.00466551818908719,0.111914665945637,0.071379774015305
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51814,-0.00160069524018778,0.0196075943526295,-0.0400315801713417,0.0368301896909661,0.93493636533445
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51814,-0.0309202461063315,0.0584647331483642,-0.145511123077125,0.0836706308644623,0.596899801544993
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51814,0.0780925354276022,0.0220889710757558,0.0347981521191208,0.121386918736084,0.00040787316484812
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51814,0.0148207173645418,0.0242064663557327,-0.0326239566926943,0.0622653914217778,0.540368918842987
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51814,0.0717062904548319,0.0267379711222082,0.0192998670553037,0.12411271385436,0.00732669634924619
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51814,-0.0122421255849504,0.00862220807542319,-0.0291416534127799,0.00465740224287904,0.155666442774728
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28049,0.0997122229703203,0.0288545443769052,0.043157315991586,0.156267129949055,0.000554347531465897
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28049,0.0637023351841458,0.0361645215163749,-0.00718012698794898,0.134584797356241,0.0782336250128307
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28049,-0.0380220292240104,0.0268119025888258,-0.0905733582981091,0.0145292998500882,0.156235191390239
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28049,0.0137828354271533,0.0222666419026502,-0.0298597827020411,0.0574254535563477,0.53595640606101
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51949,0.00864439668678363,0.00921693055613682,-0.00942078720324454,0.0267095805768118,0.348312927610751
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51949,0.0569892186886121,0.0271282285737701,0.00381789068402266,0.110160546693202,0.0356731265366113
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51949,-0.00035903279776235,0.00931423472550907,-0.0186149328597601,0.0178968672642354,0.969252090164326
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51949,-0.020370732303383,0.00904567378742244,-0.038100252926731,-0.00264121168003506,0.0243308365487379
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51949,0.0121604064605153,0.0130956446835836,-0.0135070571193085,0.0378278700403392,0.353112682826136
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51949,0.0283087733198211,0.0134914135520179,0.00186560275786598,0.0547519438817763,0.0358892602473765
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51949,0.00530329556549854,0.00998004323861503,-0.0142575891821869,0.024864180313184,0.595152724709039
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51949,0.0585802285158159,0.0284066105644977,0.00290327180940037,0.114257185222231,0.0391974844347176
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42846,-0.00322449315331457,0.00981245115742361,-0.0224568974218649,0.0160079111152357,0.742452296311504
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42846,-0.0897704251086632,0.0102858654498588,-0.109930721390387,-0.0696101288269399,2.81407606707588e-18
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42846,0.0640968618507748,0.0123182329550641,0.0399531252588492,0.0882405984427005,1.97695506861229e-07
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42847,0.0369659648461264,0.0168924219904281,0.00385681774488734,0.0700751119473654,0.0286587015375204
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42847,0.0346570094136273,0.0108796496140735,0.0133328961700432,0.0559811226572115,0.00144742974297748
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51709,-0.0417249512971218,0.0102150349478686,-0.0617464197949443,-0.0217034827992994,4.42646663284565e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51709,-0.007262570234183,0.00801529648418915,-0.0229725513431937,0.00844741087482773,0.364896701262657
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51709,0.0198215705948281,0.00957048142486812,0.00106342700208656,0.0385797141875696,0.0383572100093674
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51709,0.0094296663557514,0.0148818560183147,-0.0197387714401455,0.0385981041516483,0.526324190967347
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51724,-0.00827835452913662,0.00879590021531711,-0.0255183189511582,0.00896160989288492,0.346630734737094
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51724,-0.00758138768068939,0.0120673028187759,-0.0312333012054902,0.0160705258441115,0.529839647689098
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51814,0.0199298740328958,0.00929916449642903,0.00170351161989486,0.0381562364458967,0.0321064702021427
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51814,0.0325186278381972,0.0114344823355626,0.0101070424604946,0.0549302132158998,0.00445960986414397
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51814,0.0707217687728569,0.0171523604583429,0.0371031422745048,0.104340395271209,3.74803342288605e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51814,0.0401395350057867,0.0200009284047395,0.000937715332497299,0.0793413546790762,0.0447716700361457
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51814,0.0765942903732455,0.0197646032590602,0.0378556679854874,0.115332912761004,0.000106724804639776
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51814,0.0357288631392346,0.0282160420397808,-0.0195745792587359,0.091032305537205,0.205430339222813
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39779,-0.0145929031742368,0.00556567164348229,-0.0255016195954621,-0.00368418675301152,0.00875118945456499
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51433,0.00948729992693844,0.0166091528001099,-0.023066639561277,0.0420412394151539,0.567862538251142
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X874.Duration of walks,47823,-0.00482920336341859,0.00416026721859295,-0.0129833271118608,0.00332492038502358,0.245738211402118
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50696,0.000263945909410186,0.0162618444741917,-0.0316092692600056,0.032137161078826,0.98705022931063
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X894.Duration of moderate activity,44640,0.0246750022687257,0.019458684481051,-0.0134640193141342,0.0628140238515857,0.204786643411707
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30263,0.0211165402600089,0.00830235954232646,0.00484391555704905,0.0373891649629688,0.0110000547123744
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50710,-0.00778849964333853,0.0165774751046954,-0.0402803508485415,0.0247033515618644,0.638484410959191
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X914.Duration of vigorous activity,39725,0.011160443717878,0.00528577648797406,0.000800321801448827,0.0215205656343072,0.0347526437122385
